{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 2028, "items": [{"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T02:36:53Z", "timestamp": 1576809413698}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2016, 5, 20]]}, "DOI": "10.1200/jco.2016.34.15_suppl.1525", "type": "journal-article", "created": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T16:25:27Z", "timestamp": 1536251127000}, "page": "1525-1525", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Prostate cancer genome-wide association study from 89,000 men using the OncoArray chip to identify novel prostate cancer susceptibility loci."], "prefix": "10.1200", "volume": "34", "author": [{"given": "Rosalind", "family": "Eeles", "sequence": "first", "affiliation": [{"name": "The Institute of Cancer Research, Sutton, United Kingdom;"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.1525", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:44:41Z", "timestamp": 1574891081000}, "score": 43.245605, "issued": {"date-parts": [[2016, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/JCO.2016.34.15_suppl.1525"], "URL": "http://dx.doi.org/10.1200/jco.2016.34.15_suppl.1525", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:59:56Z", "timestamp": 1574539196205}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2013, 4, 15]]}, "DOI": "10.1158/1538-7445.am2013-4577", "type": "proceedings-article", "created": {"date-parts": [[2014, 8, 14]], "date-time": "2014-08-14T23:08:53Z", "timestamp": 1408057733000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 4577: Identification of twenty three novel prostate cancer susceptibility loci using a custom assay (the icogs) in an international consortium: PRACTICAL."], "prefix": "10.1158", "author": [{"given": "Rosalind A.", "family": "Eeles", "sequence": "first", "affiliation": []}, {"given": "Zsofia", "family": "Kote-jarai", "sequence": "additional", "affiliation": []}, {"given": "The PRACTICAL", "family": "Consortium", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 18]]}, "event": {"name": "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC"}, "container-title": ["Epidemiology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2013-4577", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T20:12:49Z", "timestamp": 1558210369000}, "score": 33.51418, "issued": {"date-parts": [[2013, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2013-4577"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2013-4577"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:10:07Z", "timestamp": 1574496607711}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2012, 4, 15]]}, "DOI": "10.1158/1538-7445.am2012-1650", "type": "proceedings-article", "created": {"date-parts": [[2012, 8, 13]], "date-time": "2012-08-13T09:56:07Z", "timestamp": 1344851767000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 1650: Overview of the clinical ELLIPSE (ELucidating Loci Involved in Prostate cancer SuscEptibility) Consortium (CEC)"], "prefix": "10.1158", "author": [{"given": "Chee L.", "family": "Goh", "sequence": "first", "affiliation": []}, {"given": "Fredrick", "family": "Schumacher", "sequence": "additional", "affiliation": []}, {"given": "Zsofia", "family": "Kote-Jarai", "sequence": "additional", "affiliation": []}, {"given": "Peter", "family": "Kraft", "sequence": "additional", "affiliation": []}, {"given": "Douglas", "family": "Easton", "sequence": "additional", "affiliation": []}, {"given": "Brian", "family": "Henderson", "sequence": "additional", "affiliation": []}, {"given": "Rosalind", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 21]]}, "event": {"name": "Proceedings: AACR 103rd Annual Meeting 2012\u2010\u2010 Mar 31\u2010Apr 4, 2012; Chicago, IL"}, "container-title": ["Epidemiology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2012-1650", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T18:48:58Z", "timestamp": 1558205338000}, "score": 31.327263, "issued": {"date-parts": [[2012, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2012-1650"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2012-1650"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T05:53:35Z", "timestamp": 1575438815950}, "publisher-location": "Berlin, Heidelberg", "reference-count": 101, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642451942", "type": "print"}, {"value": "9783642451959", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2014]]}, "DOI": "10.1007/978-3-642-45195-9_2", "type": "book-chapter", "created": {"date-parts": [[2014, 2, 17]], "date-time": "2014-02-17T17:21:52Z", "timestamp": 1392657712000}, "page": "9-26", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Germline Genetic Variants Associated with Prostate Cancer and Potential Relevance to Clinical Practice"], "prefix": "10.1007", "author": [{"given": "Chee Leng", "family": "Goh", "sequence": "first", "affiliation": []}, {"given": "Rosalind Anne", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 2, 16]]}, "reference": [{"key": "2_CR1", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1038/nature11632", "volume": "491", "author": "GR Abecasis", "year": "2012", "unstructured": "Abecasis GR, Auton A, Brooks LD et al (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491:56\u201365", "journal-title": "Nature"}, {"key": "2_CR2", "doi-asserted-by": "publisher", "first-page": "9742", "DOI": "10.1073/pnas.0910668107", "volume": "107", "author": "N Ahmadiyeh", "year": "2010", "unstructured": "Ahmadiyeh N, Pomerantz MM, Grisanzio C et al (2010) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci USA 107:9742\u20139746", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "2_CR3", "doi-asserted-by": "publisher", "first-page": "426", "DOI": "10.1038/ng.1104", "volume": "44", "author": "S Akamatsu", "year": "2012", "unstructured": "Akamatsu S, Takata R, Haiman CA et al (2012) Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat Genet 44:426\u2013429", "journal-title": "Nat Genet"}, {"key": "2_CR4", "doi-asserted-by": "publisher", "first-page": "1058", "DOI": "10.1038/ng.452", "volume": "41", "author": "AA Al Olama", "year": "2009", "unstructured": "Al Olama AA, Kote-Jarai Z, Giles GG et al (2009) Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 41:1058\u20131060", "journal-title": "Nat Genet"}, {"key": "2_CR5", "author": "AA Amin Al Olama", "year": "2013", "unstructured": "Amin Al Olama AA, Kote-Jarai Z, Schumacher FR et al (2013) A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet 22:408\u2013415", "journal-title": "Hum Mol Genet", "DOI": "10.1093/hmg/dds425", "doi-asserted-by": "publisher"}, {"key": "2_CR6", "doi-asserted-by": "publisher", "first-page": "652", "DOI": "10.1038/ng1808", "volume": "38", "author": "LT Amundadottir", "year": "2006", "unstructured": "Amundadottir LT, Sulem P, Gudmundsson J et al (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38:652\u2013658", "journal-title": "Nat Genet"}, {"key": "2_CR7", "author": "E Audet-Walsh", "year": "2011", "unstructured": "Audet-Walsh E, Bellemare J, Nadeau G et al (2011) SRD5A Polymorphisms and Biochemical Failure After Radical Prostatectomy. Eur Urol 60:1226\u20131234", "journal-title": "Eur Urol", "DOI": "10.1016/j.eururo.2011.06.020", "doi-asserted-by": "publisher"}, {"key": "2_CR8", "doi-asserted-by": "publisher", "first-page": "876", "DOI": "10.1002/ijc.26091", "volume": "130", "author": "BY Bao", "year": "2012", "unstructured": "Bao BY, Pao JB, Huang CN et al (2012) Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy. Int J Cancer 130:876\u2013884", "journal-title": "Int J Cancer"}, {"key": "2_CR9", "doi-asserted-by": "publisher", "first-page": "928", "DOI": "10.1158/1078-0432.CCR-10-2648", "volume": "17", "author": "BY Bao", "year": "2011", "unstructured": "Bao BY, Pao JB, Huang CN et al (2011) Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy. Clin Cancer Res 17:928\u2013936", "journal-title": "Clin Cancer Res"}, {"key": "2_CR10", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1016/S1470-2045(11)70302-3", "volume": "13", "author": "GC Barnett", "year": "2012", "unstructured": "Barnett GC, Coles CE, Elliott RM et al (2012) Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol 13:65\u201377", "journal-title": "Lancet Oncol"}, {"key": "2_CR11", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1007/s10689-012-9573-z", "volume": "12", "author": "PJ Barrow", "year": "2013", "unstructured": "Barrow PJ, Ingham S, O\u2019Hara C et al (2013) The spectrum of urological malignancy in Lynch syndrome. Fam Cancer 12:57\u201363", "journal-title": "Fam Cancer"}, {"key": "2_CR12", "doi-asserted-by": "publisher", "first-page": "3020", "DOI": "10.1200/JCO.2012.43.3441", "volume": "30", "author": "E Basch", "year": "2012", "unstructured": "Basch E, Oliver TK, Vickers A et al (2012) Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion. J Clin Oncol 30:3020\u20133025", "journal-title": "J Clin Oncol"}, {"key": "2_CR13", "doi-asserted-by": "publisher", "first-page": "3367", "DOI": "10.1073/pnas.89.8.3367", "volume": "89", "author": "BS Carter", "year": "1992", "unstructured": "Carter BS, Beaty TH, Steinberg GD et al (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A 89:3367\u20133371", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "2_CR14", "doi-asserted-by": "crossref", "first-page": "1748", "DOI": "10.1200/JCO.2012.43.1882", "volume": "31", "author": "E Castro", "year": "2013", "unstructured": "Castro E, Goh CL, Olmos D et al (2013) Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis and poor survival outcomes in prostate cancer. J Clin Oncol 31:1748\u20131757", "journal-title": "J Clin Oncol"}, {"key": "2_CR15", "doi-asserted-by": "publisher", "first-page": "1079", "DOI": "10.1016/j.eururo.2012.02.054", "volume": "61", "author": "MM Center", "year": "2012", "unstructured": "Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61:1079\u20131092", "journal-title": "Eur Urol"}, {"key": "2_CR16", "doi-asserted-by": "crossref", "first-page": "2446", "DOI": "10.1245/s10434-013-2884-y", "volume": "20", "author": "CF Chang", "year": "2013", "unstructured": "Chang CF, Pao JB, Yu CC, et al (2013) Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy. Ann Surg Oncol 20:2446\u20132452", "journal-title": "Ann Surg Oncol"}, {"key": "2_CR17", "doi-asserted-by": "publisher", "first-page": "4247", "DOI": "10.1200/JCO.2009.26.8771", "volume": "28", "author": "KN Chi", "year": "2010", "unstructured": "Chi KN, Hotte SJ, Yu EY et al (2010) Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer. J Clin Oncol 28:4247\u20134254", "journal-title": "J Clin Oncol"}, {"key": "2_CR18", "doi-asserted-by": "publisher", "first-page": "762", "DOI": "10.7326/0003-4819-155-11-201112060-00375", "volume": "155", "author": "R Chou", "year": "2011", "unstructured": "Chou R, Croswell JM, Dana T et al (2011) Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 155:762\u2013771", "journal-title": "Ann Intern Med"}, {"key": "2_CR19", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1093/carcin/bgp273", "volume": "31", "author": "CC Chung", "year": "2010", "unstructured": "Chung CC, Magalhaes WC, Gonzalez-Bosquet J et al (2010) Genome-wide association studies in cancer\u2013current and future directions. Carcinogenesis 31:111\u2013120", "journal-title": "Carcinogenesis"}, {"key": "2_CR20", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1016/j.urology.2003.10.013", "volume": "62", "author": "ED Crawford", "year": "2003", "unstructured": "Crawford ED (2003) Epidemiology of prostate cancer. Urology 62:3\u201312", "journal-title": "Urology"}, {"key": "2_CR21", "doi-asserted-by": "publisher", "first-page": "420", "DOI": "10.1086/318187", "volume": "68", "author": "J Cui", "year": "2001", "unstructured": "Cui J, Antoniou AC, Dite GS et al (2001) After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet 68:420\u2013431", "journal-title": "Am J Hum Genet"}, {"key": "2_CR22", "doi-asserted-by": "publisher", "first-page": "5635", "DOI": "10.1158/1078-0432.CCR-07-4999", "volume": "14", "author": "O Cussenot", "year": "2008", "unstructured": "Cussenot O, Azzouzi AR, Bantsimba-Malanda G et al (2008) Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. Clin Cancer Res 14:5635\u20135639", "journal-title": "Clin Cancer Res"}, {"key": "2_CR23", "doi-asserted-by": "publisher", "first-page": "2677", "DOI": "10.1158/0008-5472.CAN-04-0341", "volume": "64", "author": "C Cybulski", "year": "2004", "unstructured": "Cybulski C, Huzarski T, Gorski B et al (2004) A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res 64:2677\u20132679", "journal-title": "Cancer Res"}, {"key": "2_CR24", "doi-asserted-by": "publisher", "first-page": "863", "DOI": "10.1136/jmg.2006.044974", "volume": "43", "author": "C Cybulski", "year": "2006", "unstructured": "Cybulski C, Wokolorczyk D, Huzarski T et al (2006) A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer. J Med Genet 43:863\u2013866", "journal-title": "J Med Genet"}, {"key": "2_CR25", "doi-asserted-by": "publisher", "first-page": "1774", "DOI": "10.1158/1055-9965.EPI-12-0458", "volume": "21", "author": "PJ Dluzniewski", "year": "2012", "unstructured": "Dluzniewski PJ, Wang MH, Zheng SL et al (2012) Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence. Cancer Epidemiol Biomarkers Prev 21:1774\u20131782", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "2_CR26", "doi-asserted-by": "publisher", "first-page": "1836", "DOI": "10.1093/jnci/djm250", "volume": "99", "author": "D Duggan", "year": "2007", "unstructured": "Duggan D, Zheng SL, Knowlton M et al (2007) Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 99:1836\u20131844", "journal-title": "J Natl Cancer Inst"}, {"key": "2_CR27", "unstructured": "Easton DF (2004) From families to chromosomes: genetic linkage and association studies for finding cancer-predisposition genes. In: Eeles RA, Easton DF, Ponder BA, Eng C (eds) Genetic predisposition to cancer, London, Arnold", "DOI": "10.1201/b13271-5", "doi-asserted-by": "crossref"}, {"key": "2_CR28", "unstructured": "Eeles R, Kote-Jarai Z, Guy M, et al (2010) The identification of rare and common variants which predispose to prostate cancer. In: Foulkes WD, Cooney KA (eds) Male reproductive cancers; epidemiology, pathology and genetics, Springer, New York", "DOI": "10.1007/978-1-4419-0449-2_8", "doi-asserted-by": "crossref"}, {"key": "2_CR29", "doi-asserted-by": "publisher", "first-page": "1116", "DOI": "10.1038/ng.450", "volume": "41", "author": "RA Eeles", "year": "2009", "unstructured": "Eeles RA, Kote-Jarai Z, Al Olama AA et al (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 41:1116\u20131121", "journal-title": "Nat Genet"}, {"key": "2_CR30", "doi-asserted-by": "publisher", "first-page": "316", "DOI": "10.1038/ng.90", "volume": "40", "author": "RA Eeles", "year": "2008", "unstructured": "Eeles RA, Kote-Jarai Z, Giles GG et al (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40:316\u2013321", "journal-title": "Nat Genet"}, {"key": "2_CR31", "doi-asserted-by": "publisher", "first-page": "385", "DOI": "10.1038/ng.2560", "volume": "45", "author": "RA Eeles", "year": "2013", "unstructured": "Eeles RA, Olama AA, Benlloch S et al (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45:385\u2013391", "journal-title": "Nat Genet"}, {"key": "2_CR32", "doi-asserted-by": "publisher", "first-page": "4409", "DOI": "10.1200/JCO.2012.43.2278", "volume": "30", "author": "C Engel", "year": "2012", "unstructured": "Engel C, Loeffler M, Steinke V et al (2012) Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 30:4409\u20134415", "journal-title": "J Clin Oncol"}, {"key": "2_CR33", "doi-asserted-by": "publisher", "first-page": "316", "DOI": "10.1038/nature05609", "volume": "446", "author": "H Erkko", "year": "2007", "unstructured": "Erkko H, Xia B, Nikkila J et al (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316\u2013319", "journal-title": "Nature"}, {"key": "2_CR34", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1056/NEJMoa1110000", "volume": "366", "author": "CM Ewing", "year": "2012", "unstructured": "Ewing CM, Ray AM, Lange EM et al (2012) Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 366:141\u2013149", "journal-title": "N Engl J Med"}, {"key": "2_CR35", "doi-asserted-by": "publisher", "first-page": "2893", "DOI": "10.1002/ijc.25516", "volume": "127", "author": "J Ferlay", "year": "2010", "unstructured": "Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893\u20132917", "journal-title": "Int J Cancer"}, {"key": "2_CR36", "doi-asserted-by": "publisher", "first-page": "1196", "DOI": "10.1158/1055-9965.EPI-10-1299", "volume": "20", "author": "LM Fitzgerald", "year": "2011", "unstructured": "Fitzgerald LM, Kwon EM, Conomos MP et al (2011) Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev 20:1196\u20131203", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "2_CR37", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1038/ng.840", "volume": "43", "author": "ML Freedman", "year": "2011", "unstructured": "Freedman ML, Monteiro AN, Gayther SA et al (2011) Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 43:513\u2013518", "journal-title": "Nat Genet"}, {"key": "2_CR38", "doi-asserted-by": "crossref", "first-page": "666", "DOI": "10.1111/j.1464-410X.2012.11648.x", "volume": "112", "author": "CL Goh", "year": "2013", "unstructured": "Goh CL, Saunders EJ, Leongamornlert DA et al (2013) Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort. BJU Int 112:666\u2013673", "journal-title": "BJU Int"}, {"key": "2_CR39", "doi-asserted-by": "publisher", "first-page": "353", "DOI": "10.1111/j.1365-2796.2012.02511.x", "volume": "271", "author": "CL Goh", "year": "2012", "unstructured": "Goh CL, Schumacher FR, Easton D et al (2012) Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J Intern Med 271:353\u2013365", "journal-title": "J Intern Med"}, {"key": "2_CR40", "doi-asserted-by": "publisher", "first-page": "2460", "DOI": "10.1158/1055-9965.EPI-09-0058", "volume": "18", "author": "EM Grindedal", "year": "2009", "unstructured": "Grindedal EM, Moller P, Eeles R et al (2009) Germ-line mutations in mismatch repair genes associated with prostate cancer. Cancer Epidemiol Biomarkers Prev 18:2460\u20132467", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "2_CR41", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.1093/oxfordjournals.aje.a009313", "volume": "146", "author": "H Gronberg", "year": "1997", "unstructured": "Gronberg H, Damber L, Damber JE et al (1997) Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 146:552\u2013557", "journal-title": "Am J Epidemiol"}, {"key": "2_CR42", "doi-asserted-by": "publisher", "first-page": "1122", "DOI": "10.1038/ng.448", "volume": "41", "author": "J Gudmundsson", "year": "2009", "unstructured": "Gudmundsson J, Sulem P, Gudbjartsson DF et al (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 41:1122\u20131126", "journal-title": "Nat Genet"}, {"key": "2_CR44", "doi-asserted-by": "publisher", "first-page": "631", "DOI": "10.1038/ng1999", "volume": "39", "author": "J Gudmundsson", "year": "2007", "unstructured": "Gudmundsson J, Sulem P, Manolescu A et al (2007a) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39:631\u2013637", "journal-title": "Nat Genet"}, {"key": "2_CR45", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1038/ng.89", "volume": "40", "author": "J Gudmundsson", "year": "2008", "unstructured": "Gudmundsson J, Sulem P, Rafnar T et al (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40:281\u2013283", "journal-title": "Nat Genet"}, {"key": "2_CR46", "doi-asserted-by": "publisher", "first-page": "977", "DOI": "10.1038/ng2062", "volume": "39", "author": "J Gudmundsson", "year": "2007", "unstructured": "Gudmundsson J, Sulem P, Steinthorsdottir V et al (2007b) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39:977\u2013983", "journal-title": "Nat Genet"}, {"key": "2_CR47", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1038/ng.839", "volume": "43", "author": "CA Haiman", "year": "2011", "unstructured": "Haiman CA, Chen GK, Blot WJ et al (2011) Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet 43:570\u2013573", "journal-title": "Nat Genet"}, {"key": "2_CR48", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1093/jnci/djs486", "volume": "105", "author": "CA Haiman", "year": "2013", "unstructured": "Haiman CA, Stram DO, Vickers AJ et al (2013) Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations. J Natl Cancer Inst 105:237\u2013243", "journal-title": "J Natl Cancer Inst"}, {"key": "2_CR49", "unstructured": "Hindroff LA, Junkins HA, Hall PN, et al (2009) A catalog of published genome-wide association studies [Online]. Available \n                  www.genome.gov/gwastudies\n                  \n                . Accessed March 28 2013"}, {"key": "2_CR50", "doi-asserted-by": "publisher", "first-page": "3823", "DOI": "10.1158/1078-0432.CCR-07-4566", "volume": "14", "author": "SK Holt", "year": "2008", "unstructured": "Holt SK, Karyadi DM, Kwon EM et al (2008) Association of megalin genetic polymorphisms with prostate cancer risk and prognosis. Clin Cancer Res 14:3823\u20133831", "journal-title": "Clin Cancer Res"}, {"key": "2_CR51", "unstructured": "Houlston RS, Peto J (2004) Genetics and common cancers. In: Ra E, Easton DF, Ponder BA, Eng C (eds) Genetic predisposition to prostate cancer, Arnold, London", "DOI": "10.1201/b13271-23", "doi-asserted-by": "crossref"}, {"key": "2_CR52", "doi-asserted-by": "publisher", "first-page": "707", "DOI": "10.1093/annonc/mdr264", "volume": "23", "author": "CN Huang", "year": "2012", "unstructured": "Huang CN, Huang SP, Pao JB et al (2012a) Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy. Ann Oncol 23:707\u2013713", "journal-title": "Ann Oncol"}, {"key": "2_CR53", "doi-asserted-by": "publisher", "first-page": "499", "DOI": "10.1111/j.1365-2796.2011.02449.x", "volume": "271", "author": "CN Huang", "year": "2012", "unstructured": "Huang CN, Huang SP, Pao JB et al (2012b) Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy. J Intern Med 271:499\u2013509", "journal-title": "J Intern Med"}, {"key": "2_CR54", "doi-asserted-by": "publisher", "first-page": "3068", "DOI": "10.1158/1055-9965.EPI-09-0665", "volume": "18", "author": "SP Huang", "year": "2009", "unstructured": "Huang SP, Huang LC, Ting WC et al (2009) Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy. Cancer Epidemiol Biomarkers Prev 18:3068\u20133074", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "2_CR55", "doi-asserted-by": "publisher", "first-page": "312", "DOI": "10.1245/s10434-009-0698-8", "volume": "17", "author": "SP Huang", "year": "2010", "unstructured": "Huang SP, Ting WC, Chen LM et al (2010) Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy. Ann Surg Oncol 17:312\u2013322", "journal-title": "Ann Surg Oncol"}, {"key": "2_CR56", "doi-asserted-by": "publisher", "first-page": "1330", "DOI": "10.1016/j.ijrobp.2010.01.013", "volume": "79", "author": "JJ Jaboin", "year": "2011", "unstructured": "Jaboin JJ, Hwang M, Lopater Z et al (2011) The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 79:1330\u20131335", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "2_CR57", "doi-asserted-by": "publisher", "first-page": "1893", "DOI": "10.1158/1055-9965.EPI-10-0437", "volume": "19", "author": "A Jemal", "year": "2010", "unstructured": "Jemal A, Center MM, Desantis C et al (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19:1893\u20131907", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "2_CR58", "doi-asserted-by": "publisher", "first-page": "1195", "DOI": "10.1002/pros.20970", "volume": "69", "author": "AK Kader", "year": "2009", "unstructured": "Kader AK, Sun J, Isaacs SD et al (2009) Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate 69:1195\u20131205", "journal-title": "Prostate"}, {"key": "2_CR59", "doi-asserted-by": "publisher", "first-page": "1292", "DOI": "10.1016/j.ijrobp.2010.07.036", "volume": "78", "author": "SL Kerns", "year": "2010", "unstructured": "Kerns SL, Ostrer H, Stock R et al (2010) Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 78:1292\u20131300", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "2_CR60", "doi-asserted-by": "publisher", "first-page": "e21", "DOI": "10.1016/j.ijrobp.2012.08.003", "volume": "85", "author": "SL Kerns", "year": "2013", "unstructured": "Kerns SL, Stock R, Stone N et al (2013a) A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 85:e21\u2013e28", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "2_CR61", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1016/j.juro.2013.01.096", "volume": "190", "author": "SL Kerns", "year": "2013b", "unstructured": "Kerns SL, Stone NN, Stock RG et al (2013b) A two-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. J Urol 190:102\u2013108", "journal-title": "J Urol"}, {"key": "2_CR62", "doi-asserted-by": "publisher", "first-page": "240", "DOI": "10.1016/j.mayocp.2011.09.009", "volume": "87", "author": "M Kohli", "year": "2012", "unstructured": "Kohli M, Riska SM, Mahoney DW et al (2012) Germline predictors of androgen deprivation therapy response in advanced prostate cancer. Mayo Clin Proc 87:240\u2013246", "journal-title": "Mayo Clin Proc"}, {"key": "2_CR63", "doi-asserted-by": "publisher", "first-page": "1230", "DOI": "10.1038/bjc.2011.383", "volume": "105", "author": "Z Kote-Jarai", "year": "2011", "unstructured": "Kote-Jarai Z, Leongamornlert D, Saunders E et al (2011a) BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients. Br J Cancer 105:1230\u20131234", "journal-title": "Br J Cancer"}, {"key": "2_CR64", "doi-asserted-by": "publisher", "first-page": "785", "DOI": "10.1038/ng.882", "volume": "43", "author": "Z Kote-Jarai", "year": "2011", "unstructured": "Kote-Jarai Z, Olama AA, Giles GG et al (2011b) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 43:785\u2013791", "journal-title": "Nat Genet"}, {"key": "2_CR65", "unstructured": "Lange EM (2010) Identification of genetic risk factors for prostate cancer: analytic approaches using hereditary prostate cancer families. In: Foulkes WD, Cooney KA (eds) Male reproductive cancers; epidemilogy, pathology and genetics, Springer, New York", "DOI": "10.1007/978-1-4419-0449-2_7", "doi-asserted-by": "crossref"}, {"key": "2_CR66", "doi-asserted-by": "publisher", "first-page": "1344", "DOI": "10.1016/j.juro.2007.11.078", "volume": "179", "author": "BT Larson", "year": "2008", "unstructured": "Larson BT, Magi-Galluzzi C, Casey G et al (2008) Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants. J Urol 179:1344\u20131348", "journal-title": "J Urol"}, {"key": "2_CR67", "doi-asserted-by": "publisher", "first-page": "1697", "DOI": "10.1038/bjc.2012.146", "volume": "106", "author": "D Leongamornlert", "year": "2012", "unstructured": "Leongamornlert D, Mahmud N, Tymrakiewicz M et al (2012) Germline BRCA1 mutations increase prostate cancer risk. Br J Cancer 106:1697\u20131701", "journal-title": "Br J Cancer"}, {"key": "2_CR68", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1056/NEJM200007133430201", "volume": "343", "author": "P Lichtenstein", "year": "2000", "unstructured": "Lichtenstein P, Holm NV, Verkasalo PK et al (2000) Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78\u201385", "journal-title": "N Engl J Med"}, {"key": "2_CR69", "doi-asserted-by": "publisher", "first-page": "e17142", "DOI": "10.1371/journal.pone.0017142", "volume": "6", "author": "S Lindstrom", "year": "2011", "unstructured": "Lindstrom S, Schumacher F, Siddiq A et al (2011) Characterizing associations and SNP\u2013environment interactions for GWAS\u2013identified prostate cancer risk markers\u2013results from BPC3. PLoS ONE 6:e17142", "journal-title": "PLoS ONE"}, {"key": "2_CR70", "doi-asserted-by": "publisher", "first-page": "1110", "DOI": "10.1002/cncr.21704", "volume": "106", "author": "MP Mac Manus", "year": "2006", "unstructured": "Mac Manus MP, Matthews JP, Wada M et al (2006) Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer. Cancer 106:1110\u20131116", "journal-title": "Cancer"}, {"key": "2_CR71", "first-page": "549", "volume": "35", "author": "RJ Macinnis", "year": "2011", "unstructured": "Macinnis RJ, Antoniou AC, Eeles RA et al (2011) A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genet Epidemiol 35:549\u2013556", "journal-title": "Genet Epidemiol"}, {"key": "2_CR72", "first-page": "42", "volume": "34", "author": "RJ Macinnis", "year": "2010", "unstructured": "Macinnis RJ, Antoniou AC, Eeles RA et al (2010) Prostate cancer segregation analyses using 4390 families from UK and Australian population\u2013based studies. Genet Epidemiol 34:42\u201350", "journal-title": "Genet Epidemiol"}, {"key": "2_CR73", "doi-asserted-by": "publisher", "first-page": "1391", "DOI": "10.1002/pros.20427", "volume": "66", "author": "HE Maki", "year": "2006", "unstructured": "Maki HE, Waltering KK, Wallen MJ et al (2006) Screening of genetic and expression alterations of SRC1 gene in prostate cancer. Prostate 66:1391\u20131398", "journal-title": "Prostate"}, {"key": "2_CR74", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1056/NEJMra0905980", "volume": "363", "author": "TA Manolio", "year": "2010", "unstructured": "Manolio TA (2010) Genomewide association studies and assessment of the risk of disease. N Engl J Med 363:166\u2013176", "journal-title": "N Engl J Med"}, {"key": "2_CR75", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1111/j.1464-410X.2010.09648.x", "volume": "107", "author": "AV Mitra", "year": "2011", "unstructured": "Mitra AV, Bancroft EK, Barbachano Y et al (2011) Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int 107:28\u201339", "journal-title": "BJU Int"}, {"key": "2_CR76", "doi-asserted-by": "publisher", "first-page": "506", "DOI": "10.1016/j.juro.2010.03.144", "volume": "184", "author": "J Morote", "year": "2010", "unstructured": "Morote J, del Amo J, Borque A et al (2010) Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms. J Urol 184:506\u2013511", "journal-title": "J Urol"}, {"key": "2_CR77", "unstructured": "National Institute of Health (2010) ELLIPSE (Elucidating Loci Involved in Prostate Cancer Susceptibility) [Online]. Available \n                  http://epi.grants.cancer.gov/pgwas/personnel.html#ellipse\n                  \n                . Accessed 1 July 2012"}, {"key": "2_CR78", "doi-asserted-by": "publisher", "first-page": "1656", "DOI": "10.1038/bjc.2011.118", "volume": "104", "author": "N Pashayan", "year": "2011", "unstructured": "Pashayan N, Duffy SW, Chowdhury S et al (2011) Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer 104:1656\u20131663", "journal-title": "Br J Cancer"}, {"key": "2_CR79", "doi-asserted-by": "publisher", "first-page": "2062", "DOI": "10.1016/j.juro.2009.12.098", "volume": "183", "author": "CA Perez", "year": "2010", "unstructured": "Perez CA, Chen H, Shyr Y et al (2010) The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer. J Urol 183:2062\u20132069", "journal-title": "J Urol"}, {"key": "2_CR80", "unstructured": "PRACTICAL (2008) PRACTICAL (Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome) [Online]. Available \n                  http://www.srl.cam.ac.uk/consortia/practical/index.html\n                  \n                . Accessed 1 July 2012"}, {"key": "2_CR81", "doi-asserted-by": "publisher", "first-page": "935", "DOI": "10.1086/302077", "volume": "63", "author": "DJ Schaid", "year": "1998", "unstructured": "Schaid DJ (1998) Transmission disequilibrium, family controls, and great expectations. Am J Hum Genet 63:935\u2013941", "journal-title": "Am J Hum Genet"}, {"key": "2_CR82", "doi-asserted-by": "publisher", "first-page": "3867", "DOI": "10.1093/hmg/ddr295", "volume": "20", "author": "FR Schumacher", "year": "2011", "unstructured": "Schumacher FR, Berndt SI, Siddiq A et al (2011) Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet 20:3867\u20133875", "journal-title": "Hum Mol Genet"}, {"key": "2_CR83", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1016/j.eururo.2013.03.007", "volume": "64", "author": "Z Shang", "year": "2013", "unstructured": "Shang Z, Zhu S, Zhang H, et al (2013) Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in european descendants: a meta-analysis of 24 213 cases and 73 631 controls. Eur Urol 64:173\u2013176", "journal-title": "Eur Urol"}, {"key": "2_CR84", "doi-asserted-by": "publisher", "first-page": "220", "DOI": "10.3322/caac.21149", "volume": "62", "author": "R Siegel", "year": "2012", "unstructured": "Siegel R, Desantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220\u2013241", "journal-title": "CA Cancer J Clin"}, {"key": "2_CR85", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1158/1535-7163.MCT-07-0557", "volume": "7", "author": "TM Sissung", "year": "2008", "unstructured": "Sissung TM, Danesi R, Price DK et al (2008) Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel. Mol Cancer Ther 7:19\u201326", "journal-title": "Mol Cancer Ther"}, {"key": "2_CR86", "doi-asserted-by": "publisher", "first-page": "343", "DOI": "10.1002/pros.20060", "volume": "60", "author": "SS Strom", "year": "2004", "unstructured": "Strom SS, Gu Y, Zhang H et al (2004) Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. Prostate 60:343\u2013351", "journal-title": "Prostate"}, {"key": "2_CR87", "doi-asserted-by": "publisher", "first-page": "1153", "DOI": "10.1038/ng.214", "volume": "40", "author": "J Sun", "year": "2008", "unstructured": "Sun J, Zheng SL, Wiklund F et al (2008) Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet 40:1153\u20131155", "journal-title": "Nat Genet"}, {"key": "2_CR88", "doi-asserted-by": "publisher", "first-page": "30", "DOI": "10.1002/pros.21403", "volume": "72", "author": "R Szulkin", "year": "2012", "unstructured": "Szulkin R, Holmberg E, Stattin P et al (2012) Prostate cancer risk variants are not associated with disease progression. Prostate 72:30\u201339", "journal-title": "Prostate"}, {"key": "2_CR89", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1038/ng.635", "volume": "42", "author": "R Takata", "year": "2010", "unstructured": "Takata R, Akamatsu S, Kubo M et al (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 42:751\u2013754", "journal-title": "Nat Genet"}, {"key": "2_CR90", "doi-asserted-by": "publisher", "first-page": "310", "DOI": "10.1038/ng.91", "volume": "40", "author": "G Thomas", "year": "2008", "unstructured": "Thomas G, Jacobs KB, Yeager M et al (2008) Multiple loci identified in a genome\u2013wide association study of prostate cancer. Nat Genet 40:310\u2013315", "journal-title": "Nat Genet"}, {"key": "2_CR91", "doi-asserted-by": "publisher", "first-page": "2542", "DOI": "10.1158/1055-9965.EPI-06-0687", "volume": "15", "author": "D Thompson", "year": "2006", "unstructured": "Thompson D, Seal S, Schutte M et al (2006) A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers. Cancer Epidemiol Biomarkers Prev 15:2542\u20132545", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "2_CR92", "doi-asserted-by": "publisher", "first-page": "675", "DOI": "10.1002/pros.20729", "volume": "68", "author": "M Tischkowitz", "year": "2008", "unstructured": "Tischkowitz M, Sabbaghian N, Ray AM et al (2008) Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. Prostate 68:675\u2013678", "journal-title": "Prostate"}, {"key": "2_CR93", "doi-asserted-by": "publisher", "first-page": "1295", "DOI": "10.1016/j.ijrobp.2009.12.017", "volume": "76", "author": "C West", "year": "2010", "unstructured": "West C, Rosenstein BS, Alsner J et al (2010) Establishment of a Radiogenomics Consortium. Int J Radiat Oncol Biol Phys 76:1295\u20131296", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "2_CR94", "doi-asserted-by": "publisher", "first-page": "e13363", "DOI": "10.1371/journal.pone.0013363", "volume": "5", "author": "HC Whitaker", "year": "2010", "unstructured": "Whitaker HC, Kote-Jarai Z, Ross-Adams H et al (2010) The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS ONE 5:e13363", "journal-title": "PLoS ONE"}, {"key": "2_CR95", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1158/1055-9965.EPI-08-1111", "volume": "19", "author": "EJ Whitman", "year": "2010", "unstructured": "Whitman EJ, Pomerantz M, Chen Y et al (2010) Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy. Cancer Epidemiol Biomarkers Prev 19:1\u20138", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "2_CR96", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1056/NEJMoa1113162", "volume": "367", "author": "TJ Wilt", "year": "2012", "unstructured": "Wilt TJ, Brawer MK, Jones KM et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203\u2013213", "journal-title": "N Engl J Med"}, {"key": "2_CR97", "doi-asserted-by": "publisher", "first-page": "219", "DOI": "10.1086/432377", "volume": "77", "author": "J Xu", "year": "2005", "unstructured": "Xu J, Dimitrov L, Chang BL et al (2005) A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 77:219\u2013229", "journal-title": "Am J Hum Genet"}, {"key": "2_CR98", "doi-asserted-by": "publisher", "first-page": "5819", "DOI": "10.1158/1078-0432.CCR-08-0934", "volume": "14", "author": "J Xu", "year": "2008", "unstructured": "Xu J, Isaacs SD, Sun J et al (2008) Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res 14:5819\u20135824", "journal-title": "Clin Cancer Res"}, {"key": "2_CR99", "doi-asserted-by": "publisher", "first-page": "1231", "DOI": "10.1038/ng.2424", "volume": "44", "author": "J Xu", "year": "2012", "unstructured": "Xu J, Mo Z, Ye D et al (2012) Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet 44:1231\u20131235", "journal-title": "Nat Genet"}, {"key": "2_CR100", "doi-asserted-by": "publisher", "first-page": "2565", "DOI": "10.1200/JCO.2010.31.2405", "volume": "29", "author": "M Yang", "year": "2011", "unstructured": "Yang M, Xie W, Mostaghel E et al (2011) SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 29:2565\u20132573", "journal-title": "J Clin Oncol"}, {"key": "2_CR101", "doi-asserted-by": "publisher", "first-page": "645", "DOI": "10.1038/ng2022", "volume": "39", "author": "M Yeager", "year": "2007", "unstructured": "Yeager M, Orr N, Hayes RB et al (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39:645\u2013649", "journal-title": "Nat Genet"}, {"key": "2_CR102", "first-page": "492", "volume": "3", "author": "CC Yu", "year": "2013", "unstructured": "Yu CC, Lin VC, Huang CY et al (2013) Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy. Ann Surg Oncol 20 Suppl 3:492\u2013499", "journal-title": "Ann Surg Oncol 20 Suppl"}], "container-title": ["Prostate Cancer Prevention", "Recent Results in Cancer Research"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-642-45195-9_2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 26]], "date-time": "2019-05-26T07:48:52Z", "timestamp": 1558856932000}, "score": 30.99467, "issued": {"date-parts": [[2014]]}, "ISBN": ["9783642451942", "9783642451959"], "references-count": 101, "URL": "http://dx.doi.org/10.1007/978-3-642-45195-9_2", "relation": {"cites": []}, "ISSN": ["0080-0015", "2197-6767"], "issn-type": [{"value": "0080-0015", "type": "print"}, {"value": "2197-6767", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T20:30:45Z", "timestamp": 1575232245269}, "reference-count": 0, "publisher": "AME Publishing Company", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Transl. Androl. Urol."], "published-print": {"date-parts": [[2018, 2]]}, "DOI": "10.21037/tau.2017.12.30", "type": "journal-article", "created": {"date-parts": [[2018, 1, 23]], "date-time": "2018-01-23T07:12:11Z", "timestamp": 1516691531000}, "page": "61-69", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Men with a susceptibility to prostate cancer and the role of genetic based screening"], "prefix": "10.21037", "volume": "7", "author": [{"given": "Rosalind", "family": "Eeles", "sequence": "first", "affiliation": []}, {"given": "Holly Ni", "family": "Raghallaigh", "sequence": "additional", "affiliation": []}], "member": "8611", "published-online": {"date-parts": [[2018, 2]]}, "container-title": ["Translational Andrology and Urology"], "link": [{"URL": "http://tau.amegroups.com/article/download/18084/18370", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 23]], "date-time": "2018-01-23T07:12:18Z", "timestamp": 1516691538000}, "score": 29.261753, "issued": {"date-parts": [[2018, 2]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2018, 2]]}, "published-print": {"date-parts": [[2018, 2]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.21037/tau.2017.12.30", "ISSN": ["2223-4683", "2223-4691"], "issn-type": [{"value": "2223-4683", "type": "print"}, {"value": "2223-4691", "type": "electronic"}], "subject": ["Urology", "Reproductive Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T17:35:45Z", "timestamp": 1574184945146}, "reference-count": 15, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 1, 1]], "date-time": "2006-01-01T00:00:00Z", "timestamp": 1136073600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Women's Health Medicine"], "published-print": {"date-parts": [[2006, 1]]}, "DOI": "10.1383/wohm.2006.3.1.28", "type": "journal-article", "created": {"date-parts": [[2006, 3, 8]], "date-time": "2006-03-08T13:34:45Z", "timestamp": 1141824885000}, "page": "28-30", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Management of a woman with a family history of breast cancer"], "prefix": "10.1383", "volume": "3", "author": [{"given": "EL", "family": "Lynch", "sequence": "first", "affiliation": []}, {"given": "RA", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Women's Health Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1744187006001211?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1744187006001211?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 23]], "date-time": "2019-03-23T02:06:25Z", "timestamp": 1553306785000}, "score": 28.902931, "issued": {"date-parts": [[2006, 1]]}, "references-count": 15, "journal-issue": {"published-print": {"date-parts": [[2006, 1]]}, "issue": "1"}, "alternative-id": ["S1744187006001211"], "URL": "http://dx.doi.org/10.1383/wohm.2006.3.1.28", "ISSN": ["1744-1870"], "issn-type": [{"value": "1744-1870", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:19:48Z", "timestamp": 1574399988233}, "publisher-location": "Dordrecht", "reference-count": 99, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789401042949", "type": "print"}, {"value": "9789401106771", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1995]]}, "DOI": "10.1007/978-94-011-0677-1_4", "type": "book-chapter", "created": {"date-parts": [[2011, 9, 19]], "date-time": "2011-09-19T05:05:34Z", "timestamp": 1316408734000}, "page": "67-83", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The genetics of prostate cancer"], "prefix": "10.1007", "author": [{"given": "R. A.", "family": "Eeles", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "4_CR1", "unstructured": "Office of Population Censuses and Surveys. London: HMSO; 1992."}, {"key": "4_CR2", "first-page": "14", "volume": "38", "author": "E Silverberg", "year": "1989", "unstructured": "Silverberg E, Lubera JA. Cancer statistics. CA. 1989; 38: 14\u201315.", "journal-title": "CA."}, {"key": "4_CR3", "unstructured": "Cancer facts and figures. American Cancer Society. 1992."}, {"key": "4_CR4", "unstructured": "Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC. 1993: 21. chapter 21."}, {"key": "4_CR5", "first-page": "290A", "volume": "147", "author": "GP Haas", "year": "1992", "unstructured": "Haas GP, Sakr W, Cassin B et al. The prevalence of prostate cancer in young black and white males. J Urol. 1992; 147: 290A.", "journal-title": "J Urol."}, {"key": "4_CR6", "doi-asserted-by": "publisher", "first-page": "897", "DOI": "10.1097/00000478-198812000-00001", "volume": "12", "author": "JE McNeal", "year": "1988", "unstructured": "McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic carcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988; 12: 897\u2013906.", "journal-title": "Am J Surg Pathol."}, {"key": "4_CR7", "doi-asserted-by": "publisher", "first-page": "64", "DOI": "10.1016/S0046-8177(86)80156-3", "volume": "17", "author": "JE McNeal", "year": "1986", "unstructured": "McNeal JE, Boswick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol. 1986; 17: 64\u201371.", "journal-title": "Hum Pathol."}, {"key": "4_CR8", "first-page": "449", "volume": "13", "author": "GE Hanks", "year": "1987", "unstructured": "Hanks GE, Diamond JJ, Krall JM, Martz KL, Kramer S. A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys. 1987; 13: 449\u2013505.", "journal-title": "Int J Radiat Oncol Biol Phys."}, {"key": "4_CR9", "doi-asserted-by": "publisher", "first-page": "1156", "DOI": "10.1056/NEJM199104253241702", "volume": "324", "author": "WJ Catalona", "year": "1991", "unstructured": "Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991; 324: 1156\u20131161.", "journal-title": "N Engl J Med."}, {"key": "4_CR10", "doi-asserted-by": "crossref", "first-page": "1827", "DOI": "10.1016/S0022-5347(17)37041-6", "volume": "148", "author": "O Gustafsson", "year": "1992", "unstructured": "Gustafsson O, Norming U, Almgard L-E, Fredriksson A, Gustavsson G, Harvig B, Nyman CR. Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men. J Urol. 1992; 148: 1827\u20131831.", "journal-title": "J Urol."}, {"key": "4_CR11", "unstructured": "Office of Population Censuses and Surveys. London: HMSO; 1986."}, {"key": "4_CR12", "unstructured": "Waterhouse J, Muir C, Shanmugaratnam K et al. In: Cancer incidence in five continents, Vol 6. Lyon, France: IARC, Publication 42; 1982."}, {"key": "4_CR13", "doi-asserted-by": "publisher", "first-page": "982", "DOI": "10.1002/1097-0142(19890301)63:5<982::AID-CNCR2820630533>3.0.CO;2-I", "volume": "63", "author": "WP McWhorter", "year": "1989", "unstructured": "McWhorter WP, Schatztkin AG, Horm JW et al. Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer. 1989; 63: 982\u2013987.", "journal-title": "Cancer."}, {"key": "4_CR14", "first-page": "43", "volume": "40", "author": "W Haenszel", "year": "1988", "unstructured": "Haenszel W. Cancer mortality among the foreign-born in the United States. J Natl Cancer Inst. 1988; 40: 43\u201368.", "journal-title": "J Natl Cancer Inst."}, {"key": "4_CR15", "doi-asserted-by": "publisher", "first-page": "493", "DOI": "10.1111/j.1464-410X.1987.tb04862.x", "volume": "59", "author": "DG Zaridze", "year": "1987", "unstructured": "Zaridze DG, Boyle P. Cancer of the prostate: epidemiology and aetiology. Br J Urol. 1987; 59: 493\u2013502.", "journal-title": "Br J Urol."}, {"key": "4_CR16", "doi-asserted-by": "publisher", "first-page": "657", "DOI": "10.1016/0091-7435(80)90037-7", "volume": "90", "author": "P Hill", "year": "1980", "unstructured": "Hill P, Wynder EL, Games H, Walker ARP. Environmental factors, hormonal status and prostatic cancer. Prev Med. 1980; 90: 657\u2013666.", "journal-title": "Prev Med."}, {"key": "4_CR17", "doi-asserted-by": "publisher", "first-page": "104", "DOI": "10.1210/jcem-67-1-104", "volume": "67", "author": "AW Meikle", "year": "1988", "unstructured": "Meikle AW, Stringham JD, Bishop DT et al. Quantitating genetic and nongenetic factors influencing androgen production and clearance in men. J Clin Endocrinol Metab. 1988; 67: 104\u2013109.", "journal-title": "J Clin Endocrinol Metab."}, {"key": "4_CR18", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1093/oxfordjournals.aje.a112133", "volume": "102", "author": "H Armenian", "year": "1975", "unstructured": "Armenian H, Lilienfeld A, Diamond E, Bron I. Epidemiologic characteristics of patients with prostatic neoplasms. Am J Epidemiol. 1975; 102: 47\u201354.", "journal-title": "Am J Epidemiol."}, {"key": "4_CR19", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1016/0021-9681(71)90056-7", "volume": "24", "author": "R Steele", "year": "1971", "unstructured": "Steele R, Lees REM, Kraus AS, Rao C. Sexual factors in the epidemiology of cancer of the prostate. J Chron Dis. 1971; 24: 29\u201337.", "journal-title": "J Chron Dis."}, {"issue": "7", "key": "4_CR20", "doi-asserted-by": "publisher", "first-page": "935", "DOI": "10.1016/S0959-8049(05)80196-0", "volume": "29A", "author": "DCG Skegg", "year": "1993", "unstructured": "Skegg DCG. Vasectomy and risk of cancers of prostate and testis. Eur J Cancer. 1993; 29A(7): 935\u2013936.", "journal-title": "Eur J Cancer"}, {"key": "4_CR21", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1016/0021-9681(63)90091-2", "volume": "16", "author": "H King", "year": "1963", "unstructured": "King H, Diamond E, Lilienfeld A. Some epidemiological aspects of cancer of the prostate. J Chron Dis. 1963; 16: 117\u2013153.", "journal-title": "J Chron Dis."}, {"key": "4_CR22", "first-page": "181", "volume": "61", "author": "T Schuman", "year": "1977", "unstructured": "Schuman T, Mandel J, Blackard C, Bauer H, Scarlett J, McHugh R. Epidemiologic study of prostatic cancer: preliminary report. Cancer Treatment Rep. 1977; 61: 181\u2013186.", "journal-title": "Cancer Treatment Rep."}, {"key": "4_CR23", "doi-asserted-by": "publisher", "first-page": "561", "DOI": "10.1016/0090-4295(73)90516-5", "volume": "l", "author": "MM Webber", "year": "1973", "unstructured": "Webber MM, Stonington OG, Lehman J. Virus in prostatic epithelium of man. Urology. 1973;l:561\u2013567.", "journal-title": "Urology"}, {"key": "4_CR24", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1111/j.1464-410X.1976.tb06652.x", "volume": "48", "author": "RJ Ablin", "year": "1976", "unstructured": "Ablin RJ. Serum antibody in patients with prostatic cancer. Br J Urol. 1976; 48: 355\u2013361.", "journal-title": "Br J Urol."}, {"key": "4_CR25", "first-page": "140", "volume": "19", "author": "I Richardson", "year": "1965", "unstructured": "Richardson I. Prostatic cancer and social class. Br J Rev Soc Med. 1965; 19: 140\u2013142.", "journal-title": "Br J Rev Soc Med."}, {"key": "4_CR26", "doi-asserted-by": "publisher", "first-page": "344", "DOI": "10.1002/1097-0142(197108)28:2<344::AID-CNCR2820280214>3.0.CO;2-#", "volume": "28", "author": "F Wynder", "year": "1971", "unstructured": "Wynder F, Mabuchi K, Whitmore W. Epidemiology of cancer of the prostate. Cancer. 1971; 28: 344\u2013360.", "journal-title": "Cancer."}, {"key": "4_CR27", "doi-asserted-by": "publisher", "first-page": "730", "DOI": "10.1016/S0140-6736(67)92222-2", "volume": "1", "author": "MD Kipling", "year": "1967", "unstructured": "Kipling MD, Waterhouse JAH. Cadmium and prostatic carcinoma. Lancet. 1967; 1: 730\u2013731.", "journal-title": "Lancet."}, {"key": "4_CR28", "doi-asserted-by": "publisher", "first-page": "178", "DOI": "10.1097/00043764-197603000-00012", "volume": "18", "author": "AJ McMichael", "year": "1976", "unstructured": "McMichael AJ, Spirtas R, Gamble JF, Tousey PM. Mortality among rubber workers; relationship to specific jobs. J Occup Med. 1976; 18: 178\u2013185.", "journal-title": "J Occup Med."}, {"key": "4_CR29", "first-page": "47", "volume": "1", "author": "LA Cannon", "year": "1982", "unstructured": "Cannon LA, Bishop DT, Skolnick M, Hunt S, Lyon J, Smart C. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surveys. 1982; 1: 47\u201369.", "journal-title": "Cancer Surveys."}, {"key": "4_CR30", "doi-asserted-by": "publisher", "first-page": "739", "DOI": "10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E", "volume": "13", "author": "CM Woolf", "year": "1960", "unstructured": "Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer. 1960; 13: 739\u2013744.", "journal-title": "Cancer."}, {"key": "4_CR31", "first-page": "304", "volume": "6", "author": "G Morganti", "year": "1959", "unstructured": "Morganti G, Gianferrari L, Cresseri A, Arrigoni G, Lorati G. Recherches clinico-statistiques et genetiques sur les neoplasies de la prostate. Acta Genet Stat. 1959; 6: 304\u2013305.", "journal-title": "Acta Genet Stat."}, {"key": "4_CR32", "doi-asserted-by": "publisher", "first-page": "154", "DOI": "10.1016/0091-7435(74)90070-X", "volume": "3", "author": "LS Krain", "year": "1974", "unstructured": "Krain LS. Some epidemiologic variables in prostatic carcinoma in California. Prev Med. 1974; 3: 154\u2013159.", "journal-title": "Prev Med."}, {"key": "4_CR33", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1002/pros.2990170303", "volume": "17", "author": "SM Fincham", "year": "1990", "unstructured": "Fincham SM, Hill GB, Hanson J, Wijayasinghe C. Epidemiology of prostate cancer: a case control study. Prostate. 1990; 17: 189\u2013206.", "journal-title": "Prostate."}, {"key": "4_CR34", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1002/pros.2990060202", "volume": "6", "author": "AW Meikle", "year": "1985", "unstructured": "Meikle AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate. 1985; 6: 121\u2013128.", "journal-title": "Prostate."}, {"key": "4_CR35", "doi-asserted-by": "publisher", "first-page": "337", "DOI": "10.1002/pros.2990170409", "volume": "17", "author": "GS Steinberg", "year": "1990", "unstructured": "Steinberg GS et al. Family history and the risk of prostate cancer. Prostate. 1990; 17: 337\u2013347.", "journal-title": "Prostate."}, {"key": "4_CR36", "doi-asserted-by": "crossref", "first-page": "1305", "DOI": "10.1016/S0022-5347(17)38074-6", "volume": "146", "author": "MR Spitz", "year": "1991", "unstructured": "Spitz MR, Currier RD, Fueger JJ, Babaian J, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol. 1991; 146: 1305\u20131307.", "journal-title": "J Urol."}, {"key": "4_CR37", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1002/pros.2990190105", "volume": "19", "author": "P Ghadirian", "year": "1991", "unstructured": "Ghadirian P, Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate. 1991; 19: 43\u201352.", "journal-title": "Prostate."}, {"key": "4_CR38", "unstructured": "Cancer in Utah Report No. 3. 1967-1977. Salt Lake City: Utah Cancer Registry; 1977."}, {"key": "4_CR39", "author": "MH Skolnick", "first-page": "285", "year": "1980", "unstructured": "Skolnick MH. The Utah genealogical data base: a resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick MH, eds. Banbury Report No. 4: Cancer incidence in defined populations. New York: Cold Spring Harbor Laboratory; 1980: 285\u2013297.", "volume-title": "Banbury Report No. 4: Cancer incidence in defined populations"}, {"key": "4_CR40", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1080/00324728.1978.10412788", "volume": "32", "author": "M Skolnick", "year": "1978", "unstructured": "Skolnick M, Bean L, May D, Arbon V, de Nevers K, Cartwright P. Mormon demographic history. I. Nuptiality and fertility of once-married couples. Popul Stud. 1978; 32: 5\u201319.", "journal-title": "Popul Stud."}, {"key": "4_CR41", "first-page": "836", "volume": "36", "author": "T McLellan", "year": "1984", "unstructured": "McLellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet. 1984; 36: 836\u2013837.", "journal-title": "Am J Hum Genet."}, {"key": "4_CR42", "first-page": "105", "volume": "56-57", "author": "LB Jorde", "year": "1981", "unstructured": "Jorde LB, Skolnick MH. Demographic and genetic application of computerized record linking: the Utah Mormon genealogy. Inf Sci Hum. 1981; 56-57: 105\u2013117.", "journal-title": "Inf Sci Hum."}, {"key": "4_CR43", "unstructured": "Malecot G. Les mathematiques de l\u2019heredite. Masson et Cie. 1948; Paris."}, {"key": "4_CR44", "first-page": "2378", "volume": "54", "author": "LA Cannon-Albright", "year": "1994", "unstructured": "Cannon-Albright LA, Thomas A, Goldgar DE et al. Familiality of cancer in Utah. Cancer Res. 1994; 54: 2378\u20132385.", "journal-title": "Cancer Res."}, {"key": "4_CR45", "doi-asserted-by": "publisher", "first-page": "3367", "DOI": "10.1073/pnas.89.8.3367", "volume": "89", "author": "BS Carter", "year": "1992", "unstructured": "Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA. 1992; 89: 3367\u20133371.", "journal-title": "Proc Natl Acad Sci USA."}, {"key": "4_CR46", "first-page": "1437", "volume": "45", "author": "AG Knudson", "year": "1985", "unstructured": "Knudson AG. Hereditary cancer, oncogenes and antioncogenes. Cancer Res. 1985; 45: 1437\u20131443.", "journal-title": "Cancer Res."}, {"key": "4_CR47", "doi-asserted-by": "publisher", "first-page": "458", "DOI": "10.1038/363458a0", "volume": "363", "author": "LM Mulligan", "year": "1993", "unstructured": "Mulligan LM, Kwok JBJ, Healey CS et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993; 363: 458\u2013460.", "journal-title": "Nature."}, {"key": "4_CR48", "doi-asserted-by": "publisher", "first-page": "1027", "DOI": "10.1016/0092-8674(93)90546-3", "volume": "75", "author": "R Fishel", "year": "1993", "unstructured": "Fishel R, Lescoe MK, Rao MRS et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993; 75: 1027\u20131038.", "journal-title": "Cell."}, {"key": "4_CR49", "doi-asserted-by": "publisher", "first-page": "1215", "DOI": "10.1016/0092-8674(93)90330-S", "volume": "75", "author": "FS Leach", "year": "1993", "unstructured": "Leach FS, Nicolaides NC, Papadopoulos N et al. Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer. Cell. 1993; 75: 1215\u20131225.", "journal-title": "Cell."}, {"key": "4_CR50", "author": "MT Macklin", "first-page": "1074", "year": "1954", "unstructured": "Macklin MT. The genetic basis of human mammary cancer. In: Proceedings of the second national cancer conference. New York: American Cancer Society; 1954; 1074\u20131087.", "volume-title": "Proceedings of the second national cancer conference"}, {"key": "4_CR51", "doi-asserted-by": "publisher", "first-page": "1102", "DOI": "10.1002/1097-0142(197410)34:4<1102::AID-CNCR2820340421>3.0.CO;2-5", "volume": "34", "author": "E Thiessen", "year": "1974", "unstructured": "Thiessen E. Concerning a familial association between breast cancer and both prostatic and uterine malignancies. Cancer. 1974; 34: 1102\u20131107.", "journal-title": "Cancer."}, {"key": "4_CR52", "doi-asserted-by": "publisher", "first-page": "855", "DOI": "10.1136/bmj.305.6858.855", "volume": "305", "author": "H Tulinius", "year": "1992", "unstructured": "Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ. 1992; 305: 855\u2013857.", "journal-title": "BMJ."}, {"key": "4_CR53", "doi-asserted-by": "publisher", "first-page": "1114", "DOI": "10.1093/jnci/84.14.1114", "volume": "84", "author": "DE Anderson", "year": "1992", "unstructured": "Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. JNCI. 1992; 84: 1114\u20131117.", "journal-title": "JNCI."}, {"key": "4_CR54", "doi-asserted-by": "publisher", "first-page": "692", "DOI": "10.1016/S0140-6736(94)91578-4", "volume": "343", "author": "D Ford", "year": "1994", "unstructured": "Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE and the Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet. 1994; 343: 692\u2013695.", "journal-title": "Lancet."}, {"key": "4_CR55", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.1016/S0022-5347(17)35617-3", "volume": "150", "author": "BS Carter", "year": "1993", "unstructured": "Carter BS, Bova GS, Beaty TH et al. Hereditary prostate cancer; epidemiologic and clinical features. J Urol. 1993; 150: 797\u2013802.", "journal-title": "J Urol."}, {"key": "4_CR56", "doi-asserted-by": "crossref", "first-page": "665", "DOI": "10.1093/oxfordjournals.aje.a115388", "volume": "130", "author": "SH Zahm", "year": "1989", "unstructured": "Zahm SH, Blair A, Holmes FF, Boysen CD, Robel RJ, Fraumeni JF Jr. A case-control study of soft tissue sarcoma. Am J Epid. 1989; 130: 665\u2013674.", "journal-title": "Am J Epid."}, {"key": "4_CR57", "first-page": "1298", "volume": "54", "author": "JM Birch", "year": "1994", "unstructured": "Birch JM, Hartley AL, Tricker KJ et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994; 54: 1298\u20131304.", "journal-title": "Cancer Res."}, {"key": "4_CR58", "first-page": "1269", "volume": "8", "author": "RA Eeles", "year": "1993", "unstructured": "Eeles RA, Warren W, Knee G et al. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple independent primary tumours: molecular and immunohistochemical findings. Oncogene. 1993; 8: 1269\u20131276.", "journal-title": "Oncogene."}, {"key": "4_CR59", "doi-asserted-by": "publisher", "first-page": "368", "DOI": "10.1016/0046-8177(92)90083-F", "volume": "23", "author": "AA Sandberg", "year": "1992", "unstructured": "Sandberg AA. Chromosomal abormalities and related events in prostate cancer. Hum Pathol. 1992; 23: 368\u2013380.", "journal-title": "Hum Pathol."}, {"key": "4_CR60", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1016/0165-4608(84)90020-7", "volume": "11", "author": "Z Gibas", "year": "1984", "unstructured": "Gibas Z et al. Chromosome rearrangement in a metastatic adenocarcinoma of the prostate. Cancer Genet Cytogenet. 1984; 11: 399\u2013404.", "journal-title": "Cancer Genet Cytogenet."}, {"key": "4_CR61", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1007/BF00295378", "volume": "70", "author": "N Atkin", "year": "1985", "unstructured": "Atkin N, Baker M. Chromosome study of 5 cancers of the prostate. Hum Genet. 1985; 70: 359\u2013364.", "journal-title": "Hum Genet."}, {"key": "4_CR62", "doi-asserted-by": "publisher", "first-page": "16", "DOI": "10.1002/gcc.2870040103", "volume": "4", "author": "R Lundgren", "year": "1992", "unstructured": "Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer. 1992; 4: 16\u201324.", "journal-title": "Genes Chromosomes Cancer."}, {"key": "4_CR63", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1016/0165-4608(93)90234-D", "volume": "66", "author": "S Arps", "year": "1993", "unstructured": "Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H. Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet. 1993; 66: 93\u201399.", "journal-title": "Cancer Genet Cytogenet."}, {"key": "4_CR64", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1016/0165-4608(93)90164-H", "volume": "67", "author": "NB Atkin", "year": "1993", "unstructured": "Atkin NB, Baker MC. Chromosome 7q deletions: observations on 13 malignant tumors. Cancer Genet Cytogenet. 1993; 67: 123\u2013125.", "journal-title": "Cancer Genet Cytogenet."}, {"key": "4_CR65", "first-page": "3795", "volume": "50", "author": "AR Brothman", "year": "1990", "unstructured": "Brothman AR, Peehl DM, Patel AM, McNeal JE. Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res. 1990; 50: 3795\u20133803.", "journal-title": "Cancer Res."}, {"key": "4_CR66", "doi-asserted-by": "publisher", "first-page": "8751", "DOI": "10.1073/pnas.87.22.8751", "volume": "87", "author": "BS Carter", "year": "1990", "unstructured": "Carter BS, Ewing CM, Ward WS et al. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA. 1990; 87: 8751\u20138755.", "journal-title": "Proc Natl Acad Sci USA."}, {"key": "4_CR67", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.3109/02841869109092347", "volume": "30", "author": "VP Collins", "year": "1991", "unstructured": "Collins VP, Kunimi K, Bergerheim U, Ekman P. Molecular genetics and human prostatic carcinoma. Acta Oncol. 1991; 30: 181\u2013185.", "journal-title": "Acta Oncol."}, {"key": "4_CR68", "first-page": "3869", "volume": "53", "author": "GS Bova", "year": "1993", "unstructured": "Bova GS, Carter BS, Bussemakers MJG et al. Homozygous deletion and frequent allele loss of chromosome 8p22 loci in human prostate cancer. Cancer Res. 1993; 53: 3869\u20133873.", "journal-title": "Cancer Res."}, {"key": "4_CR69", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1002/gcc.2870030308", "volume": "3", "author": "USR Bergerheim", "year": "1991", "unstructured": "Bergerheim USR, Kunimi K, Collins VP, Ekman P. Deletion mapping of chromosomes 8, 10 and 16 in human prostate carcinoma. Genes Chromosomes Cancer. 1991; 3: 215\u2013220.", "journal-title": "Genes Chromosomes Cancer."}, {"key": "4_CR70", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1126/science.1905840", "volume": "253", "author": "MC Hollstein", "year": "1991", "unstructured": "Hollstein MC, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991; 253: 49\u201353.", "journal-title": "Science."}, {"key": "4_CR71", "doi-asserted-by": "publisher", "first-page": "1657", "DOI": "10.1093/jnci/85.20.1657", "volume": "85", "author": "NM Navone", "year": "1993", "unstructured": "Navone NM, Troncosco P, Pisters LL, et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. JNCI. 1993; 85: 1657\u20131669.", "journal-title": "JNCI."}, {"key": "4_CR72", "doi-asserted-by": "publisher", "first-page": "7762", "DOI": "10.1073/pnas.87.19.7762", "volume": "87", "author": "R Bookstein", "year": "1990", "unstructured": "Bookstein R, Rio P, Madreperla SA et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate cancer. Proc Natl Acad Sci USA. 1990; 87: 7762\u20137766.", "journal-title": "Proc Natl Acad Sci USA."}, {"key": "4_CR73", "first-page": "2827", "volume": "54", "author": "Y Dobashi", "year": "1994", "unstructured": "Dobashi Y, Shuin T, Tsuruga H, Uemura H, Torigoe S, Kubota Y. DNA polymerase \u03b2 gene mutation in human prostate cancer. Cancer Res. 1994; 54: 2827\u20132829.", "journal-title": "Cancer Res."}, {"key": "4_CR74", "first-page": "2299", "volume": "54", "author": "T Ichikawa", "year": "1994", "unstructured": "Ichikawa T, Niheii N, Suzuki H et al. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res. 1994; 54: 2299\u20132302.", "journal-title": "Cancer Res."}, {"key": "4_CR75", "first-page": "3486", "volume": "52", "author": "T Ichikawa", "year": "1992", "unstructured": "Ichikawa T, Ichikawa Y, Dong J et al. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res. 1992; 52: 3486\u20133490.", "journal-title": "Cancer Res."}, {"key": "4_CR76", "first-page": "3077", "volume": "54", "author": "NG Berube", "year": "1994", "unstructured": "Berube NG, Speevak MD, Chevrette M. Suppression of tumorigenicity of human prostate cancer cells by introduction of human chromosome del(12)(q13). Cancer Res. 1994; 54: 3077\u20133081.", "journal-title": "Cancer Res."}, {"key": "4_CR77", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1002/pros.2990100402", "volume": "10", "author": "DM Peehl", "year": "1987", "unstructured": "Peehl DM, Wehner N, Stamey TA. Activated Ki-ras oncogene in human prostatic adenocarci-noma. Prostate. 1987; 10: 281\u2013289.", "journal-title": "Prostate."}, {"key": "4_CR78", "first-page": "6830", "volume": "50", "author": "BS Carter", "year": "1992", "unstructured": "Carter BS, Epstein JI, Isaacs WB. ras gene mutations in human prostate cancer. Cancer Res. 1992; 50: 6830\u20136832.", "journal-title": "Cancer Res."}, {"key": "4_CR79", "doi-asserted-by": "crossref", "first-page": "786", "DOI": "10.1016/0277-5379(90)90152-J", "volume": "7", "author": "H Sumiya", "year": "1990", "unstructured": "Sumiya H, Masai MN, Akimoto S, Yatani R, Shimazaki J. Histological examination of expression of ras p21 protein and R1881 binding protein in human prostatic cancer. Eur J Cancer. 1990; 7: 786\u2013789.", "journal-title": "Eur J Cancer."}, {"key": "4_CR80", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1056/NEJM198601163140301", "volume": "314", "author": "MV Viola", "year": "1986", "unstructured": "Viola MV, Fromowitz F, Oravez S et al. Expression of ras oncogene p21 in prostate cancer. N Engl J Med. 1986; 314: 133\u2013137.", "journal-title": "N Engl J Med."}, {"key": "4_CR81", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1016/S0022-5347(17)42397-4", "volume": "139", "author": "K Fan", "year": "1988", "unstructured": "Fan K. Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of p21 as a predictor for bone metastasis. J Urol. 1988; 139: 318\u2013322.", "journal-title": "J Urol."}, {"key": "4_CR82", "doi-asserted-by": "crossref", "first-page": "1580", "DOI": "10.1016/S0022-5347(17)42131-8", "volume": "140", "author": "B Treiger", "year": "1988", "unstructured": "Treiger B, Isaacs J. Expression of a transfected v-H-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability. J Urol. 1988; 140: 1580\u20131586.", "journal-title": "J Urol."}, {"key": "4_CR83", "first-page": "2042", "volume": "48", "author": "JA Schalken", "year": "1988", "unstructured": "Schalken JA, Ebeling SB, Issacs JT et al. Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis. Cancer Res. 1988; 48: 2042\u20132046.", "journal-title": "Cancer Res."}, {"key": "4_CR84", "first-page": "6050", "volume": "48", "author": "AW Partin", "year": "1988", "unstructured": "Partin AW, Isaacs JT, Treiger B, Coffey DS. Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with v-Harvey-ras oncogene. Cancer Res. 1988; 48: 6050\u20136053.", "journal-title": "Cancer Res."}, {"key": "4_CR85", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1002/pros.2990180209", "volume": "18", "author": "T Ichikawa", "year": "1991", "unstructured": "Ichikawa T, Schalken JA, Ichikawa Y, Steinberg G, Isaacs JT. H-ras expression, genetic instability and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transfection. Prostate. 1991; 18: 163\u2013172.", "journal-title": "Prostate."}, {"key": "4_CR86", "first-page": "3788", "volume": "51", "author": "T Ichikawa", "year": "1991", "unstructured": "Ichikawa T, Ichikawa Y, Isaacs JT. Genetic factors and suppression of metastatic ability of prostatic cancer. Cancer Res. 1991; 51: 3788\u20133792.", "journal-title": "Cancer Res."}, {"key": "4_CR87", "doi-asserted-by": "publisher", "first-page": "327", "DOI": "10.1002/pros.2990110405", "volume": "11", "author": "R Buttyan", "year": "1987", "unstructured": "Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA. Enhanced expression of the c-myc proto-oncogene in high grade human prostate cancers. Prostate. 1987; 11: 327\u2013337.", "journal-title": "Prostate."}, {"key": "4_CR88", "first-page": "6940", "volume": "52", "author": "TJ McDonnell", "year": "1992", "unstructured": "McDonnell TJ, Troncoso P, Brisbay SM et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992; 52: 6940\u20136944.", "journal-title": "Cancer Res."}, {"key": "4_CR89", "first-page": "2916", "volume": "52", "author": "MJG Bussemakers", "year": "1992", "unstructured": "Bussemakers MJG, van Moorselaar RJA, Giroldi LA et al. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res. 1992; 52: 2916\u20132922.", "journal-title": "Cancer Res."}, {"key": "4_CR90", "doi-asserted-by": "publisher", "first-page": "114", "DOI": "10.1007/BF01613138", "volume": "117", "author": "MS Pajouh", "year": "1991", "unstructured": "Pajouh MS, Nagole RB, Breathnach R, Finch JS, Brawer MK, Bowden GT. Expression of met-alloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol. 1991; 117: 114\u2013150.", "journal-title": "J Cancer Res Clin Oncol."}, {"key": "4_CR91", "doi-asserted-by": "publisher", "first-page": "274", "DOI": "10.1002/ijc.2910210305", "volume": "21", "author": "KR Stone", "year": "1978", "unstructured": "Stone KR, Mickey DD, Wunderli H, Mickey G, Paulson DF. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer. 1978; 21: 274\u2013281.", "journal-title": "Int J Cancer."}, {"key": "4_CR92", "first-page": "1809", "volume": "43", "author": "JS Horoszewicz", "year": "1983", "unstructured": "Horoszewicz JS, Leong SS, Kawinski E et al. LNCaP model of human prostatic carcinoma. Cancer Res. 1983; 43: 1809\u20131818.", "journal-title": "Cancer Res."}, {"key": "4_CR93", "first-page": "16", "volume": "17", "author": "ME Kaighn", "year": "1979", "unstructured": "Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and chracterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979; 17: 16\u201323.", "journal-title": "Invest Urol."}, {"key": "4_CR94", "doi-asserted-by": "crossref", "first-page": "1064", "DOI": "10.1016/S0022-5347(17)53345-5", "volume": "128", "author": "JL Ware", "year": "1982", "unstructured": "Ware JL, Paulson DF, Mickey GH, Webb KS. Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. J Urol. 1982; 128: 1064.", "journal-title": "J Urol."}, {"key": "4_CR95", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1007/BF00262024", "volume": "17", "author": "GJ Steenbrugge", "year": "1989", "unstructured": "Steenbrugge GJ, van Groen M, van Dongen JW et al. The human prostatic carcinoma cell line LNCaP and its derivatives. Urol Res. 1989; 17: 71.", "journal-title": "Urol Res."}, {"key": "4_CR96", "first-page": "971", "volume": "6", "author": "DM Parkin", "year": "1993", "unstructured": "Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J. Cancer incidence in five continents. IARC. 1993; 6: 971.", "journal-title": "IARC"}, {"key": "4_CR97", "doi-asserted-by": "crossref", "first-page": "826", "DOI": "10.1016/S0022-5347(17)36733-2", "volume": "148", "author": "WP McWhorter", "year": "1992", "unstructured": "McWhorter WP, Hernandez AD, Meikle AW et al. A screening study of prostate cancer in high risk families. J Urol. 1992; 148: 826\u2013828.", "journal-title": "J Urol."}, {"key": "4_CR98", "doi-asserted-by": "publisher", "first-page": "1197", "DOI": "10.1001/jama.1981.03320110013015", "volume": "246", "author": "HT Lynch", "year": "1981", "unstructured": "Lynch HT, Albano WA, Recabaren JA et al. Survival in hereditary breast and colon cancer. JAMA. 1981; 246: 1197.", "journal-title": "JAMA"}, {"key": "4_CR99", "doi-asserted-by": "publisher", "first-page": "1801", "DOI": "10.1093/jnci/85.22.1801", "volume": "85", "author": "F Donodeo", "year": "1994", "unstructured": "Donodeo F. Prevention trial for prostate cancer piques public interest. JNCI. 1994; 85: 1801\u20131802.", "journal-title": "JNCI."}], "container-title": ["Cancer Biology and Medicine", "The Genetics of Cancer"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-94-011-0677-1_4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 5]], "date-time": "2019-11-05T00:55:11Z", "timestamp": 1572915311000}, "score": 28.077702, "issued": {"date-parts": [[1995]]}, "ISBN": ["9789401042949", "9789401106771"], "references-count": 99, "URL": "http://dx.doi.org/10.1007/978-94-011-0677-1_4", "relation": {"cites": []}, "ISSN": ["0928-8945"], "issn-type": [{"value": "0928-8945", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:41:23Z", "timestamp": 1574113283581}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1999, 1, 1]], "date-time": "1999-01-01T00:00:00Z", "timestamp": 915148800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate Cancer Prostatic Dis"], "published-print": {"date-parts": [[1999, 1]]}, "DOI": "10.1038/sj.pcan.4500279", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T20:07:26Z", "timestamp": 1031170046000}, "page": "9-15", "source": "Crossref", "is-referenced-by-count": 35, "title": ["Genetic predisposition to prostate cancer"], "prefix": "10.1038", "volume": "2", "author": [{"given": "RA", "family": "Eeles", "sequence": "first", "affiliation": []}, {"name": "the UK Familial Prostate Study Co-ordinating Group", "sequence": "first", "affiliation": []}, {"name": "the CRC/BPG UK Familial Prostate Cancer Study Collaborators", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1999, 2, 22]]}, "container-title": ["Prostate Cancer and Prostatic Diseases"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/4500279.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4500279", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4500279.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T15:24:31Z", "timestamp": 1555341871000}, "score": 28.013838, "issued": {"date-parts": [[1999, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 1]]}, "issue": "1"}, "alternative-id": ["BF4500279"], "URL": "http://dx.doi.org/10.1038/sj.pcan.4500279", "ISSN": ["1365-7852", "1476-5608"], "issn-type": [{"value": "1365-7852", "type": "print"}, {"value": "1476-5608", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:59:24Z", "timestamp": 1574690364234}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2014, 10, 1]]}, "DOI": "10.1158/1538-7445.am2014-sy32-02", "type": "proceedings-article", "created": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T21:53:01Z", "timestamp": 1430517181000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract SY32-02: Genetic predisposition to prostate cancer (PrCa) and its clinical application"], "prefix": "10.1158", "author": [{"given": "Rosalind A.", "family": "Eeles", "sequence": "first", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 9, 30]]}, "event": {"name": "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA"}, "container-title": ["Epidemiology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2014-SY32-02", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T16:05:10Z", "timestamp": 1558195510000}, "score": 26.994303, "issued": {"date-parts": [[2014, 9, 30]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2014-SY32-02"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2014-sy32-02"}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T02:46:39Z", "timestamp": 1574822799120}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2016, 7, 15]]}, "DOI": "10.1158/1538-7445.am2016-2565", "type": "proceedings-article", "created": {"date-parts": [[2016, 7, 26]], "date-time": "2016-07-26T17:58:31Z", "timestamp": 1469555911000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Abstract 2565: Prostate cancer GWAS from more than 89,000 men identifies more than 30 novel prostate cancer susceptibility loci"], "prefix": "10.1158", "author": [{"given": "Fredrick R.", "family": "Schumacher", "sequence": "first", "affiliation": []}, {"given": "Ali A.", "family": "Al Olama", "sequence": "additional", "affiliation": []}, {"given": "Sonja I.", "family": "Berndt", "sequence": "additional", "affiliation": []}, {"given": "Fredrik", "family": "Wiklund", "sequence": "additional", "affiliation": []}, {"given": "David V.", "family": "Conti", "sequence": "additional", "affiliation": []}, {"given": "Mahbubl", "family": "Ahmed", "sequence": "additional", "affiliation": []}, {"given": "Sarah", "family": "Benlloch", "sequence": "additional", "affiliation": []}, {"given": "Douglas F.", "family": "Easton", "sequence": "additional", "affiliation": []}, {"given": "Peter", "family": "Kraft", "sequence": "additional", "affiliation": []}, {"given": "Stephen J.", "family": "Chanock", "sequence": "additional", "affiliation": []}, {"given": "Brian E.", "family": "Henderson", "sequence": "additional", "affiliation": []}, {"given": "Zsofia", "family": "Kote-Jarai", "sequence": "additional", "affiliation": []}, {"given": "Christopher A.", "family": "Haiman", "sequence": "additional", "affiliation": []}, {"given": "Rosalind A.", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 7, 22]]}, "event": {"name": "Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA"}, "container-title": ["Epidemiology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2016-2565", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T16:18:53Z", "timestamp": 1558196333000}, "score": 26.44064, "issued": {"date-parts": [[2016, 7, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2016-2565"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2016-2565"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T09:02:46Z", "timestamp": 1575277366787}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "1_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2017, 2, 20]]}, "DOI": "10.1200/jco.2017.35.6_suppl.1.2017.1.test", "type": "journal-article", "created": {"date-parts": [[2018, 4, 9]], "date-time": "2018-04-09T14:05:36Z", "timestamp": 1523282736000}, "page": "1-1", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Prostate cancer meta-analysis from more than 145,000 men to identify 65 novel prostate cancer susceptibility loci."], "prefix": "10.1200", "volume": "2017", "author": [{"given": "Rosalind", "family": "Eeles", "sequence": "first", "affiliation": [{"name": "The Institute of Cancer Research, Sutton, United Kingdom;"}]}, {"given": "Ali Amin", "family": "Al Olama", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, United Kingdom;"}]}, {"given": "Sonja", "family": "Berndt", "sequence": "additional", "affiliation": [{"name": "National Cancer Institute at the National Institutes of Health, Bethesda, MD;"}]}, {"given": "Fredrik", "family": "Wiklund", "sequence": "additional", "affiliation": [{"name": "Karolinska Institutet, Department of Medical Epidemology and Biostatistics, Stockholm, Sweden;"}]}, {"given": "David V", "family": "Conti", "sequence": "additional", "affiliation": [{"name": "Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California,Department of Preventive Medicine, Division of Biostatistics, Los Angeles, CA;"}]}, {"given": "Mahbubl", "family": "Ahmed", "sequence": "additional", "affiliation": [{"name": "Institute of Cancer Research, London, United Kingdom;"}]}, {"given": "Sara", "family": "Benlloch", "sequence": "additional", "affiliation": [{"name": "The Institute of Cancer Research, London, United Kingdom;"}]}, {"given": "Douglas", "family": "Easton", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom;"}]}, {"given": "Peter", "family": "Kraft", "sequence": "additional", "affiliation": [{"name": "Harvard School of Public Health, Boston, MA;"}]}, {"given": "Stephen J.", "family": "Chanock", "sequence": "additional", "affiliation": [{"name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute at the National Institutes of Health, Bethesda, MD;"}]}, {"given": "Zsofia", "family": "Kote-Jarai", "sequence": "additional", "affiliation": [{"name": "The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;"}]}, {"given": "Christopher", "family": "Haiman", "sequence": "additional", "affiliation": [{"name": "University of Southern California, Los Angeles, CA;"}]}, {"given": "Fredrick R", "family": "Schumacher", "sequence": "additional", "affiliation": [{"name": "Case Western Reserve University, Cleveland, OH;"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.35.6_suppl.1.2017.1.test", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:24:16Z", "timestamp": 1574893456000}, "score": 26.44064, "issued": {"date-parts": [[2017, 2, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 2, 20]]}, "issue": "1_suppl"}, "alternative-id": ["10.1200/JCO.2017.35.6_suppl.1.2017.1.test"], "URL": "http://dx.doi.org/10.1200/jco.2017.35.6_suppl.1.2017.1.test", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:53:56Z", "timestamp": 1576799636819}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "6_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2017, 2, 20]]}, "abstract": "<jats:p> 1 </jats:p><jats:p> Background: Currently genome-wide association studies (GWAS) have identified over 100 prostate cancer (PrCa) susceptibility loci, capturing 33% of the PrCa familial relative risk (FRR) in Europeans. To identify further susceptibility variants, we conducted a PrCa GWAS, larger than previous studies, comprising ~49,000 cases and ~29,000 controls among individuals of European and Asian descent using the OncoArray, a platform consisting of a 260K GWAS backbone and 310K custom content selected from previous GWAS and fine-mapping studies of multiple cancers ( http://epi.grants.cancer.gov/oncoarray/ ). Methods: Genotypes from the OncoArray were used to impute genotypes from ~70M variants using the October 2014 release of the 1000 genomes project as a reference, and then combined with several previous PrCa GWAS of European ancestry: UK stage 1 (1,906 cases/1,934 controls) and stage 2 (3,888 cases/3,956 controls); CaPS 1 (498 cases/502 controls) and CaPS 2 (1,483 cases/519 controls); BPC3 (2,137 cases/3,101 controls); NCI PEGASUS (4,622 cases/2,954 controls); and iCOGS (21,209 cases/ 20,440 controls). Risk analyses for overall PrCa risk, aggressive PrCa (several definitions defined by PrCa clinical characteristics), and Gleason score were performed. Logistic and linear regression summary statistics were meta-analysed using an inverse variance fixed effect approach. Results: We identified novel loci significantly associated ( P &lt; 5.0x10<jats:sup>-8</jats:sup>) with overall PrCa (N = 65). Our novel findings are comprised of several missense variants, including a SNP in the ATM gene - a key member of the DNA repair pathway. When combined multiplicatively, the 65 novel PrCa loci identified here increases the captured heritability of PrCa, explaining 38.5% of the FRR when combining novel and previously identified PrCa loci. Conclusions: In risk stratification, men in the top 1% of the genetic risk score group have a relative risk of 5.6 fold for developing PrCa compared with the median risk group. These results will improve the utility of genetic risk scores for targeted screening and prevention for prostate cancer. </jats:p>", "DOI": "10.1200/jco.2017.35.6_suppl.1", "type": "journal-article", "created": {"date-parts": [[2017, 3, 29]], "date-time": "2017-03-29T15:03:53Z", "timestamp": 1490799833000}, "page": "1-1", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Prostate cancer meta-analysis from more than 145,000 men to identify 65 novel prostate cancer susceptibility loci."], "prefix": "10.1200", "volume": "35", "author": [{"given": "Rosalind", "family": "Eeles", "sequence": "first", "affiliation": [{"name": "The Institute of Cancer Research, Sutton, United Kingdom;"}]}, {"given": "Ali Amin", "family": "Al Olama", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, United Kingdom;"}]}, {"given": "Sonja", "family": "Berndt", "sequence": "additional", "affiliation": [{"name": "National Cancer Institute at the National Institutes of Health, Bethesda, MD;"}]}, {"given": "Fredrik", "family": "Wiklund", "sequence": "additional", "affiliation": [{"name": "Karolinska Institutet, Department of Medical Epidemology and Biostatistics, Stockholm, Sweden;"}]}, {"given": "David V", "family": "Conti", "sequence": "additional", "affiliation": [{"name": "Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California,Department of Preventive Medicine, Division of Biostatistics, Los Angeles, CA;"}]}, {"given": "Mahbubl", "family": "Ahmed", "sequence": "additional", "affiliation": [{"name": "Institute of Cancer Research, London, United Kingdom;"}]}, {"given": "Sara", "family": "Benlloch", "sequence": "additional", "affiliation": [{"name": "The Institute of Cancer Research, London, United Kingdom;"}]}, {"given": "Douglas", "family": "Easton", "sequence": "additional", "affiliation": [{"name": "Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom;"}]}, {"given": "Peter", "family": "Kraft", "sequence": "additional", "affiliation": [{"name": "Harvard School of Public Health, Boston, MA;"}]}, {"given": "Stephen J.", "family": "Chanock", "sequence": "additional", "affiliation": [{"name": "Division of Cancer Epidemiology and Genetics, National Cancer Institute at the National Institutes of Health, Bethesda, MD;"}]}, {"given": "Zsofia", "family": "Kote-Jarai", "sequence": "additional", "affiliation": [{"name": "The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;"}]}, {"given": "Christopher", "family": "Haiman", "sequence": "additional", "affiliation": [{"name": "University of Southern California, Los Angeles, CA;"}]}, {"given": "Fredrick R", "family": "Schumacher", "sequence": "additional", "affiliation": [{"name": "Case Western Reserve University, Cleveland, OH;"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.35.6_suppl.1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:41:24Z", "timestamp": 1574890884000}, "score": 26.44064, "issued": {"date-parts": [[2017, 2, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 2, 20]]}, "issue": "6_suppl"}, "alternative-id": ["10.1200/JCO.2017.35.6_suppl.1"], "URL": "http://dx.doi.org/10.1200/jco.2017.35.6_suppl.1", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T12:46:41Z", "timestamp": 1574167601676}, "reference-count": 5, "publisher": "Elsevier BV", "issue": "9377", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 7, 1]], "date-time": "2003-07-01T00:00:00Z", "timestamp": 1057017600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet"], "published-print": {"date-parts": [[2003, 7]]}, "DOI": "10.1016/s0140-6736(03)13823-8", "type": "journal-article", "created": {"date-parts": [[2003, 7, 7]], "date-time": "2003-07-07T15:02:07Z", "timestamp": 1057590127000}, "page": "80", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer"], "prefix": "10.1016", "volume": "362", "author": [{"given": "Marc", "family": "Tischkowitz", "sequence": "first", "affiliation": []}, {"given": "Ros", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0140673603138238?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0140673603138238?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T07:55:45Z", "timestamp": 1552895745000}, "score": 25.74366, "issued": {"date-parts": [[2003, 7]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2003, 7]]}, "issue": "9377"}, "alternative-id": ["S0140673603138238"], "URL": "http://dx.doi.org/10.1016/s0140-6736(03)13823-8", "ISSN": ["0140-6736"], "issn-type": [{"value": "0140-6736", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T23:53:16Z", "timestamp": 1574725996128}, "reference-count": 58, "publisher": "Oxford University Press (OUP)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br Med Bull"], "published-print": {"date-parts": [[2016, 12]]}, "DOI": "10.1093/bmb/ldw039", "type": "journal-article", "created": {"date-parts": [[2016, 12, 14]], "date-time": "2016-12-14T10:30:46Z", "timestamp": 1481711446000}, "page": "75-89", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Genetic predisposition to prostate cancer"], "prefix": "10.1093", "volume": "120", "author": [{"given": "S.", "family": "Benafif", "sequence": "first", "affiliation": []}, {"given": "R.", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2016, 10, 6]]}, "reference": [{"key": "2017011001405086000_120.1.75.1", "unstructured": "Cancer Research UK. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer (January 2016, date last accessed)."}, {"key": "2017011001405086000_120.1.75.2", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1177/107327480701400111", "article-title": "Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea", "volume": "14", "author": "Lee", "year": "2007", "journal-title": "Cancer Control"}, {"key": "2017011001405086000_120.1.75.3", "DOI": "10.1093/jnci/djt157", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.4", "doi-asserted-by": "crossref", "first-page": "9135", "DOI": "10.3402/gha.v5i0.9135", "article-title": "Prostate cancer in Germany among migrants from the Former Soviet Unio", "volume": "5", "author": "Winkler", "year": "2012", "journal-title": "Glob Health Action"}, {"key": "2017011001405086000_120.1.75.5", "DOI": "10.1056/NEJM200007133430201", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.6", "DOI": "10.1093/jnci/86.21.1600", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.7", "unstructured": "Lange EM , Male reproductive cancers: epidemiology, pathology and genetics. Cancer Genetics Springer."}, {"key": "2017011001405086000_120.1.75.8", "first-page": "4056", "article-title": "Evaluation of prostate cancer characteristics in four populations worldwide", "volume": "15", "author": "Zeigler-Johnson", "year": "2008", "journal-title": "Can J Urol"}, {"key": "2017011001405086000_120.1.75.9", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1038/nrurol.2013.266", "article-title": "The genetic epidemiology of prostate cancer and its clinical implications", "volume": "11", "author": "Eeles", "year": "2014", "journal-title": "Nat Rev Urol"}, {"key": "2017011001405086000_120.1.75.10", "DOI": "10.1038/nature04226", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.11", "DOI": "10.1038/nature11632", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.12", "DOI": "10.1093/bmb/ldq038", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.13", "DOI": "10.1038/ng1999", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.14", "DOI": "10.1038/ng.3094", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.15", "DOI": "10.1056/NEJMoa1110000", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.16", "DOI": "10.1086/318181", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.17", "DOI": "10.1016/j.eururo.2014.10.022", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.18", "DOI": "10.1186/s13073-014-0091-5", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.19", "doi-asserted-by": "crossref", "first-page": "21393", "DOI": "10.18632/oncotarget.7250", "article-title": "A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population", "volume": "7", "author": "Marzec", "year": "2016", "journal-title": "Oncotarget"}, {"key": "2017011001405086000_120.1.75.20", "DOI": "10.1158/0008-5472.CAN-09-4074", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.21", "DOI": "10.1016/j.eururo.2012.05.054", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.22", "DOI": "10.1038/ng.90", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.23", "DOI": "10.1002/(SICI)1097-0045(19991001)41:2<99::AID-PROS4>3.0.CO;2-C", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.24", "DOI": "10.1016/S0022-5347(05)00695-6", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.25", "DOI": "10.1007/s00439-012-1182-2", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.26", "DOI": "10.1002/humu.22176", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.27", "DOI": "10.1093/carcin/bgr187", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.28", "DOI": "10.7326/0003-4819-155-11-201112060-00375", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.29", "unstructured": "Public Health England, UK National Screening Committee . http://legacy.screening.nhs.uk/prostatecancer (January 2016, date last accessed)."}, {"key": "2017011001405086000_120.1.75.30", "DOI": "10.1007/s10552-007-9083-8", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.31", "DOI": "10.1016/S1470-2045(10)70146-7", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.32", "DOI": "10.1126/scitranslmed.3001513", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.33", "DOI": "10.1016/j.gene.2014.11.059", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.34", "DOI": "10.1371/journal.pone.0136735", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.35", "DOI": "10.1002/pros.23012", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.36", "DOI": "10.1016/S1470-2045(15)00361-7", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.37", "DOI": "10.1002/jso.23584", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.38", "DOI": "10.1016/j.eururo.2015.09.004", "doi-asserted-by": "crossref"}, {"key": "2017011001405086000_120.1.75.39", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1016/j.eururo.2015.09.004", "article-title": "Associations between iCOGS single nucleotide polymorphisms and upgrading in both surgical and active surveillance cohorts of men with prostate cancer", "volume": "69", "author": "Kearns", "year": "2016", "journal-title": "Eur Urol"}, {"key": "2017011001405086000_120.1.75.40", "DOI": "10.1038/ncomms7889", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.41", "DOI": "10.1016/j.ijrobp.2010.07.036", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.42", "DOI": "10.1016/j.juro.2013.01.096", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.43", "DOI": "10.1016/j.radonc.2014.02.012", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.44", "DOI": "10.1038/ng.3020", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.45", "DOI": "10.1016/j.ijrobp.2012.08.003", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.46", "DOI": "10.2217/fon.14.173", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.47", "DOI": "10.1016/S1470-2045(11)70302-3", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.48", "DOI": "10.1016/j.semradonc.2015.05.006", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.49", "DOI": "10.1007/s00439-012-1229-4", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.50", "DOI": "10.1242/dev.00432", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.51", "DOI": "10.1186/1476-4598-9-124", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.52", "DOI": "10.1038/bjc.2012.146", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.53", "DOI": "10.1056/NEJMoa1506859", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.54", "DOI": "10.1016/j.eururo.2014.01.003", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.55", "DOI": "10.1038/bjc.2014.30", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.56", "DOI": "10.1056/NEJMoa1603144", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.57", "DOI": "10.1007/s12687-011-0042-4", "doi-asserted-by": "publisher"}, {"key": "2017011001405086000_120.1.75.58", "DOI": "10.1158/2159-8290.CD-15-0714", "doi-asserted-by": "publisher"}], "container-title": ["British Medical Bulletin"], "language": "en", "link": [{"URL": "https://academic.oup.com/bmb/article/120/1/75/2527493/Genetic-predisposition-to-prostate-cancer", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 16]], "date-time": "2019-09-16T14:05:34Z", "timestamp": 1568642734000}, "score": 25.74366, "issued": {"date-parts": [[2016, 10, 6]]}, "references-count": 58, "journal-issue": {"published-online": {"date-parts": [[2016, 12, 9]]}, "published-print": {"date-parts": [[2016, 12]]}, "issue": "1"}, "alternative-id": ["10.1093/bmb/ldw039"], "URL": "http://dx.doi.org/10.1093/bmb/ldw039", "relation": {"cites": []}, "ISSN": ["0007-1420", "1471-8391"], "issn-type": [{"value": "0007-1420", "type": "print"}, {"value": "1471-8391", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T07:02:58Z", "timestamp": 1574751778405}, "reference-count": 133, "publisher": "Future Science Ltd", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Future Science OA"], "published-print": {"date-parts": [[2016, 3]]}, "DOI": "10.4155/fso.15.87", "type": "journal-article", "created": {"date-parts": [[2015, 12, 18]], "date-time": "2015-12-18T10:11:34Z", "timestamp": 1450433494000}, "source": "Crossref", "is-referenced-by-count": 5, "title": ["Germline genetic profiling in prostate cancer: latest developments and potential clinical applications"], "prefix": "10.2144", "volume": "2", "author": [{"given": "Mahbubl", "family": "Ahmed", "sequence": "first", "affiliation": []}, {"given": "Rosalind", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "2641", "container-title": ["Future Science OA"], "language": "en", "link": [{"URL": "https://www.future-science.com/doi/pdf/10.4155/fso.15.87", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:44:10Z", "timestamp": 1574243050000}, "score": 25.74366, "issued": {"date-parts": [[2016, 3]]}, "references-count": 133, "journal-issue": {"published-print": {"date-parts": [[2016, 3]]}, "issue": "1"}, "alternative-id": ["10.4155/fso.15.87"], "URL": "http://dx.doi.org/10.4155/fso.15.87", "ISSN": ["2056-5623"], "issn-type": [{"value": "2056-5623", "type": "electronic"}], "article-number": "fso.15.87"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T16:59:19Z", "timestamp": 1575478759626}, "reference-count": 1, "publisher": "Mark Allen Group", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["British Journal of Hospital Medicine"], "published-print": {"date-parts": [[2013, 5]]}, "DOI": "10.12968/hmed.2013.74.5.250", "type": "journal-article", "created": {"date-parts": [[2014, 5, 23]], "date-time": "2014-05-23T12:40:45Z", "timestamp": 1400848845000}, "page": "250-250", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Prostate cancer patients with BRCA2 mutations require urgent treatment"], "prefix": "10.12968", "volume": "74", "author": [{"given": "Ros", "family": "Eeles", "sequence": "first", "affiliation": [{"name": "Oncogenetics at The Institute of Cancer Research and Honorary Consultant in Clinical Oncology at The Royal Marsden"}]}], "member": "5130", "reference": [{"key": "B1", "author": "Castro E", "year": "2013", "volume-title": "Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer"}], "container-title": ["British Journal of Hospital Medicine"], "language": "en", "link": [{"URL": "http://www.magonlinelibrary.com/doi/pdf/10.12968/hmed.2013.74.5.250", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 22]], "date-time": "2017-12-22T13:19:34Z", "timestamp": 1513948774000}, "score": 25.654888, "issued": {"date-parts": [[2013, 5]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[2013, 5]]}, "issue": "5"}, "alternative-id": ["10.12968/hmed.2013.74.5.250"], "URL": "http://dx.doi.org/10.12968/hmed.2013.74.5.250", "relation": {"cites": []}, "ISSN": ["1750-8460", "1759-7390"], "issn-type": [{"value": "1750-8460", "type": "print"}, {"value": "1759-7390", "type": "electronic"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:21:18Z", "timestamp": 1574216478651}, "publisher-location": "London", "reference-count": 133, "publisher": "Springer-Verlag", "isbn-type": [{"value": "185233911X", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/1-84628-015-x_2", "type": "book-chapter", "created": {"date-parts": [[2006, 6, 26]], "date-time": "2006-06-26T02:14:09Z", "timestamp": 1151288049000}, "page": "17-30", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Familial Prostate Cancer"], "prefix": "10.1007", "author": [{"given": "Sashi S.", "family": "Kommu", "sequence": "first", "affiliation": []}, {"given": "Rosalind A.", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "2_CR1", "author": "American Cancer Society", "year": "2004", "unstructured": "American Cancer Society. Cancer Facts and Figures 2004. Atlanta: American Cancer Society, 2004.", "volume-title": "Cancer Facts and Figures 2004"}, {"key": "2_CR2", "unstructured": "AIHW and AACR. AIHW National Mortality Database, Australia\u2019s Health 2004, AIHW."}, {"issue": "9", "key": "2_CR3", "doi-asserted-by": "crossref", "first-page": "1058", "DOI": "10.1046/j.1464-410x.2000.00661.x", "volume": "85", "author": "A. Majeed", "year": "2000", "unstructured": "Majeed A, Babb P, Jones J, Quinn M. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971\u20131998. BJU Int 2000;85(9):1058\u20131062.", "journal-title": "BJU Int"}, {"issue": "3", "key": "2_CR4", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1159/000474185", "volume": "30", "author": "G.A. Dijkman", "year": "1996", "unstructured": "Dijkman GA, Debruyne FM. Epidemiology of prostate cancer. Eur Urol 1996;30(3):281\u2013295.", "journal-title": "Eur Urol"}, {"issue": "4", "key": "2_CR5", "doi-asserted-by": "crossref", "first-page": "594", "DOI": "10.1002/ijc.2910540413", "volume": "54", "author": "D.M. Parkin", "year": "1993", "unstructured": "Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54(4):594\u2013606.", "journal-title": "Int J Cancer"}, {"issue": "8", "key": "2_CR6", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1093/oxfordjournals.aje.a117495", "volume": "141", "author": "A.S. Whittemore", "year": "1995", "unstructured": "Whittemore AS, Wu AH, Kolonel LN, et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995;141(8):732\u2013740.", "journal-title": "Am J Epidemiol"}, {"issue": "5", "key": "2_CR7", "first-page": "562", "volume": "20", "author": "O. Cussenot", "year": "2004", "unstructured": "Cussenot O, Cancel-Tassin G. Genetic susceptibility to prostate cancer. Med Sci (Paris) 2004;20(5):562\u2013568 (French).", "journal-title": "Med Sci"}, {"key": "2_CR8", "first-page": "304", "volume": "6", "author": "G. Morganti", "year": "1959", "unstructured": "Morganti G, et al. Recherches clinico-statistiques et g\u00e9n\u00e9tiques sur les n\u00e9opasies de la prostate. Acta Genet Statist 1959;6:304\u2013305.", "journal-title": "Acta Genet Statist"}, {"issue": "5291", "key": "2_CR9", "doi-asserted-by": "crossref", "first-page": "1371", "DOI": "10.1126/science.274.5291.1371", "volume": "274", "author": "J.R. Smith", "year": "1996", "unstructured": "Smith JR, Freije D, Carpten JD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274(5291):1371\u20131374.", "journal-title": "Science"}, {"issue": "1", "key": "2_CR10", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1038/sj.pcan.4500279", "volume": "2", "author": "R. t. Eeles", "year": "1999", "unstructured": "Eeles RA, the UK Familial Prostate Study Coordinating Group and the CRC/BPG UK Familial Prostate Cancer Study Collaborators. Genetic predisposition to prostate cancer. Prostate Cancer Prostatic Dis 1999;2(1):9\u201315.", "journal-title": "Prostate Cancer Prostatic Dis"}, {"issue": "6", "key": "2_CR11", "doi-asserted-by": "crossref", "first-page": "1367", "DOI": "10.1086/316916", "volume": "67", "author": "E.A. Ostrander", "year": "2000", "unstructured": "Ostrander EA, Stanford JL. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 2000;67(6):1367\u20131375.", "journal-title": "Am J Hum Genet"}, {"issue": "2", "key": "2_CR12", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1677/erc.0.0100225", "volume": "10", "author": "J. Simard", "year": "2003", "unstructured": "Simard J, Dumont M, Labuda D, et al. Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer 2003;10(2):225\u2013259.", "journal-title": "Endocr Relat Cancer"}, {"issue": "4", "key": "2_CR13", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1002/pros.10300", "volume": "57", "author": "D.F. Easton", "year": "2003", "unstructured": "Easton DF, Schaid DJ, Whittemore AS, Isaacs WJ. International Consortium for Prostate Cancer Genetics. Where are the prostate cancer genes? A summary of eight genome wide searches. Prostate 2003;57(4):261\u2013269.", "journal-title": "Prostate"}, {"issue": "4988", "key": "2_CR14", "doi-asserted-by": "crossref", "first-page": "1684", "DOI": "10.1126/science.2270482", "volume": "250", "author": "J.M. Hall", "year": "1990", "unstructured": "Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250(4988):1684\u20131689.", "journal-title": "Science"}, {"issue": "2", "key": "2_CR15", "first-page": "304", "volume": "6", "author": "G. Morganti", "year": "1956", "unstructured": "Morganti G, Gianferrari L, Cresseri A, Arrigoni G, Lovati G. [Clinico-statistical and genetic research on neoplasms of the prostate]. Acta Genet Stat Med 1956\u20131957;6(2):304\u2013305.", "journal-title": "Acta Genet Stat Med"}, {"key": "2_CR16", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E", "volume": "13", "author": "C.M. Woolf", "year": "1960", "unstructured": "Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960;13:739\u2013744.", "journal-title": "Cancer"}, {"key": "2_CR17", "first-page": "47", "volume": "1", "author": "L. Cannon", "year": "1982", "unstructured": "Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon Genealogy. Cancer Surv 1982;1:47\u201369.", "journal-title": "Cancer Surv"}, {"issue": "4", "key": "2_CR18", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1038/ng0495-336", "volume": "9", "author": "L. Cannon-Albright", "year": "1995", "unstructured": "Cannon-Albright L, Eeles RA. Progress in prostate cancer. Nat Genet 1995;9(4):336\u2013338.", "journal-title": "Nat Genet"}, {"issue": "1", "key": "2_CR19", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/0021-9681(71)90056-7", "volume": "24", "author": "R. Steele", "year": "1971", "unstructured": "Steele R, Lees RE, Kraus AS, Rao C. Sexual factors in the epidemiology of cancer of the prostate. J Chronic Dis 1971;24(1):29\u201337.", "journal-title": "J Chronic Dis"}, {"issue": "1", "key": "2_CR20", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1016/0091-7435(74)90070-X", "volume": "3", "author": "L.S. Krain", "year": "1974", "unstructured": "Krain LS. Some epidemiologic variables in prostatic carcinoma in California. Prev Med 1974;3(1):154\u2013159.", "journal-title": "Prev Med"}, {"issue": "2", "key": "2_CR21", "first-page": "181", "volume": "61", "author": "L.M. Schuman", "year": "1977", "unstructured": "Schuman LM, Mandel J, Blackard C, Bauer H, Scarlett J, McHugh R. Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep 1977;61(2):181\u2013186.", "journal-title": "Cancer Treat Rep"}, {"issue": "2", "key": "2_CR22", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1002/pros.2990060202", "volume": "6", "author": "A.W. Meikle", "year": "1985", "unstructured": "Meikle AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate 1985;6(2):121\u2013128.", "journal-title": "Prostate"}, {"issue": "4", "key": "2_CR23", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1002/pros.2990170409", "volume": "17", "author": "G.D. Steinberg", "year": "1990", "unstructured": "Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17(4):337\u2013347.", "journal-title": "Prostate"}, {"issue": "3", "key": "2_CR24", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1002/pros.2990170303", "volume": "17", "author": "S.M. Fincham", "year": "1990", "unstructured": "Fincham SM, Hill GB, Hanson J, Wijayasinghe C. Epidemiology of prostatic cancer: a case-control study. Prostate 1990;17(3):189\u2013206.", "journal-title": "Prostate"}, {"issue": "5", "key": "2_CR25", "doi-asserted-by": "crossref", "first-page": "1305", "DOI": "10.1016/S0022-5347(17)38074-6", "volume": "146", "author": "M.R. Spitz", "year": "1991", "unstructured": "Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991;146(5):1305\u20131307.", "journal-title": "J Urol"}, {"issue": "1", "key": "2_CR26", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1002/pros.2990190105", "volume": "19", "author": "P. Ghadirian", "year": "1991", "unstructured": "Ghadirian P, Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate 1991;19(1):43\u201352.", "journal-title": "Prostate"}, {"issue": "8", "key": "2_CR27", "doi-asserted-by": "crossref", "first-page": "732", "DOI": "10.1093/oxfordjournals.aje.a117495", "volume": "141", "author": "A.S. Whittemore", "year": "1995", "unstructured": "Whittemore AS, Wu AH, Kolonel LN, et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995;141(8):732\u2013740.", "journal-title": "Am J Epidemiol"}, {"issue": "3", "key": "2_CR28", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1002/ijc.2910600315", "volume": "60", "author": "R.B. Hayes", "year": "1995", "unstructured": "Hayes RB, Liff JM, Pottern LM, et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 1995;60(3):361\u2013364.", "journal-title": "Int J Cancer"}, {"issue": "13", "key": "2_CR29", "doi-asserted-by": "crossref", "first-page": "991", "DOI": "10.1093/jnci/87.13.991", "volume": "87", "author": "S.D. Isaacs", "year": "1995", "unstructured": "Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995;87(13):991\u2013996.", "journal-title": "J Natl Cancer Inst"}, {"issue": "6", "key": "2_CR30", "doi-asserted-by": "crossref", "first-page": "2100", "DOI": "10.1016/S0022-5347(01)66705-3", "volume": "154", "author": "D.W. Keetch", "year": "1995", "unstructured": "Keetch DW, Rice JP, Suarez BK, Catalona WJ. Familial aspects of prostate cancer: a case control study. J Urol 1995;154(6):2100\u20132102.", "journal-title": "J Urol"}, {"issue": "11", "key": "2_CR31", "doi-asserted-by": "crossref", "first-page": "1041", "DOI": "10.1093/oxfordjournals.aje.a008876", "volume": "144", "author": "S.M. Lesko", "year": "1996", "unstructured": "Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 1996;144(11):1041\u20131047.", "journal-title": "Am J Epidemiol"}, {"issue": "6", "key": "2_CR32", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1002/(SICI)1097-0215(19970317)70:6<679::AID-IJC9>3.0.CO;2-S", "volume": "70", "author": "P. Ghadirian", "year": "1997", "unstructured": "Ghadirian P, Howe GR, Hislop TG, Maisonneuve P. Family history of prostate cancer: a multicenter case-control study in Canada. Int J Cancer 1997;70(6):679\u2013681.", "journal-title": "Int J Cancer"}, {"issue": "3", "key": "2_CR33", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1016/S0090-4295(98)00200-3", "volume": "52", "author": "F.E. Glover Jr", "year": "1998", "unstructured": "Glover FE Jr, Coffey DS, Douglas LL, et al. Familial study of prostate cancer in Jamaica. Urology 1998;52(3):441\u2013443.", "journal-title": "Urology"}, {"issue": "2", "key": "2_CR34", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1016/S0959-8049(98)00358-X", "volume": "35", "author": "O. Bratt", "year": "1999", "unstructured": "Bratt O, Kristoffersson U, Lundgren R, Olsson H. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 1999;35(2):272\u2013277.", "journal-title": "Eur J Cancer"}, {"issue": "suppl 1", "key": "2_CR35", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1111/j.1464-410X.1997.tb00795.x", "volume": "79", "author": "R.A. Eeles", "year": "1997", "unstructured": "Eeles RA, Dearnaley DP, Ardern-Jones A, et al. Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study. Br J Urol 1997;79(suppl 1):8\u201314.", "journal-title": "Br J Urol"}, {"issue": "4", "key": "2_CR36", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1038/sj.pcan.4500478", "volume": "3", "author": "R. Singh", "year": "2000", "unstructured": "Singh R, Eeles RA, Durocher F, et al. High risk genes predisposing to prostate cancer development-do they exist? Prostate Cancer Prostatic Dis 2000;3(4):241\u2013247.", "journal-title": "Prostate Cancer Prostatic Dis"}, {"issue": "9", "key": "2_CR37", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1046/j.1464-410X.2003.04232.x", "volume": "91", "author": "L.E. Johns", "year": "2003", "unstructured": "Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003;91(9):789\u2013794.", "journal-title": "BJU Int"}, {"issue": "8", "key": "2_CR38", "doi-asserted-by": "crossref", "first-page": "3367", "DOI": "10.1073/pnas.89.8.3367", "volume": "89", "author": "B.S. Carter", "year": "1992", "unstructured": "Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992;89(8):3367\u20133371.", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "21", "key": "2_CR39", "doi-asserted-by": "crossref", "first-page": "1600", "DOI": "10.1093/jnci/86.21.1600", "volume": "86", "author": "D.E. Goldgar", "year": "1994", "unstructured": "Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86(21):1600\u20131608.", "journal-title": "J Natl Cancer Inst"}, {"issue": "1", "key": "2_CR40", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5", "volume": "77", "author": "H. Gronberg", "year": "1996", "unstructured": "Gronberg H, Damber L, Damber JE. Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 1996;77(1):138\u2013143.", "journal-title": "Cancer"}, {"issue": "4", "key": "2_CR41", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.1093/jnci/89.4.287", "volume": "89", "author": "A. Ahlbom", "year": "1997", "unstructured": "Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL. Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst 1997;89(4):287\u2013293.", "journal-title": "J Natl Cancer Inst"}, {"issue": "4", "key": "2_CR42", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1002/(SICI)1097-0045(19971201)33:4<240::AID-PROS3>3.0.CO;2-L", "volume": "33", "author": "W.F. Page", "year": "1997", "unstructured": "Page WF, Braun MM, Partin AW, Caporaso N, Walsh P. Heredity and prostate cancer: a study of World War II veteran twins. Prostate 1997;33(4):240\u2013245.", "journal-title": "Prostate"}, {"issue": "6", "key": "2_CR43", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1002/(SICI)1097-0215(19991210)83:6<743::AID-IJC8>3.0.CO;2-Q", "volume": "83", "author": "P.K. Verkasalo", "year": "1999", "unstructured": "Verkasalo PK, Kaprio J, Koskenvuo M, Pukkala E. Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976\u20131995. Int J Cancer 1999;83(6):743\u2013749.", "journal-title": "Int J Cancer"}, {"issue": "2", "key": "2_CR44", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1056/NEJM200007133430201", "volume": "343", "author": "P. Lichtenstein", "year": "2000", "unstructured": "Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343(2):78\u201385.", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "2_CR45", "doi-asserted-by": "crossref", "first-page": "1425", "DOI": "10.1086/301862", "volume": "62", "author": "D.J. Schaid", "year": "1998", "unstructured": "Schaid DJ, McDonnell SK, Blute ML, Thibodeau SN. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998;62(6):1425\u20131438.", "journal-title": "Am J Hum Genet"}, {"issue": "2", "key": "2_CR46", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1038/nm0295-99", "volume": "1", "author": "S.A. Narod", "year": "1995", "unstructured": "Narod SA, Dupont A, Cusan L, et al. The impact of family history on early detection of prostate cancer. Nat Med 1995;1(2):99\u2013101.", "journal-title": "Nat Med"}, {"issue": "8", "key": "2_CR47", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1038/nm0895-827", "volume": "1", "author": "K.R. Monroe", "year": "1995", "unstructured": "Monroe KR, Yu MC, Kolonel LN, et al. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995;1(8):827\u2013829.", "journal-title": "Nat Med"}, {"issue": "1\u20132", "key": "2_CR48", "first-page": "56", "volume": "49", "author": "A.A. Ewis", "year": "2002", "unstructured": "Ewis AA, Lee J, Naroda T, et al. Linkage between prostate cancer incidence and different alleles of the human Y-linked tetranucleotide polymorphism DYS19. J Med Invest 2002;49(1\u20132):56\u201360.", "journal-title": "J Med Invest"}, {"issue": "5", "key": "2_CR49", "doi-asserted-by": "crossref", "first-page": "1207", "DOI": "10.1086/320114", "volume": "68", "author": "J. Cui", "year": "2001", "unstructured": "Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG. Segregation analyses of 1,476 population-based Australian families affected by prostate cancer. Am J Hum Genet 2001;68(5):1207\u20131218.", "journal-title": "Am J Hum Genet"}, {"issue": "5", "key": "2_CR50", "doi-asserted-by": "crossref", "first-page": "630", "DOI": "10.1002/ijc.11128", "volume": "105", "author": "E.M. Conlon", "year": "2003", "unstructured": "Conlon EM, Goode EL, Gibbs M, et al. Oligogenic segregation analysis of hereditary prostate cancer pedigrees: evidence for multiple loci affecting age at onset. Int J Cancer 2003;105(5):630\u2013635.", "journal-title": "Int J Cancer"}, {"key": "2_CR51", "year": "2004", "edition": "2nd ed.", "unstructured": "Eeles RAPB, Easton DF, Ponder BAJ, Eng C, eds. Genetic Predisposition to Cancer, 2nd ed. London: Arnold, 2004.", "volume-title": "Genetic Predisposition to Cancer"}, {"issue": "8", "key": "2_CR52", "doi-asserted-by": "publisher", "first-page": "618", "DOI": "10.1136/jmg.31.8.618", "volume": "31", "author": "H. Tulinius", "year": "1994", "unstructured": "Tulinius H, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Bjarnadottir K. Neoplastic diseases in families of breast cancer patients. J Med Genet 1994;31(8):618\u2013621.", "journal-title": "J Med Genet"}, {"key": "2_CR53", "unstructured": "Anderson DE, Badzioch MD. Familial breast cancer risks. Effects of prostate and other cancers. Cancer 72:114\u2013119.", "DOI": "10.1002/1097-0142(19930701)72:1<114::AID-CNCR2820720122>3.0.CO;2-0", "doi-asserted-by": "crossref"}, {"key": "2_CR54", "doi-asserted-by": "crossref", "first-page": "692", "DOI": "10.1016/S0140-6736(94)91578-4", "volume": "343", "author": "D. Ford", "year": "1994", "unstructured": "Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692\u2013695.", "journal-title": "Lancet"}, {"key": "2_CR55", "unstructured": "Thompson D, Easton DF, and the Breast Cancer Linkage Consortium. Cancer Incidence in BRCA1 Mutation Carriers. J Natl Cancer Inst 94:1358\u20131365.", "DOI": "10.1093/jnci/94.18.1358", "doi-asserted-by": "crossref"}, {"key": "2_CR56", "doi-asserted-by": "crossref", "first-page": "1337", "DOI": "10.1016/S0140-6736(98)03300-5", "volume": "352", "author": "S. Thorlacius", "year": "1998", "unstructured": "Thorlacius S, Struewing JP, Hartge P, et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 1998;352:1337\u20131339.", "journal-title": "Lancet"}, {"key": "2_CR57", "doi-asserted-by": "crossref", "first-page": "758", "DOI": "10.1007/s001090050162", "volume": "75", "author": "S. Sigurdsson", "year": "1997", "unstructured": "Sigurdsson S, Thorlacius S, Tomasson J, et al. BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 1997;75:758\u2013761.", "journal-title": "J Mol Med"}, {"key": "2_CR58", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1002/1098-2264(2000)9999:9999<::AID-GCC1090>3.0.CO;2-U", "volume": "30", "author": "H. Gronberg", "year": "2001", "unstructured": "Gronberg H, Ahman AK, Emanuelsson M, Bergh A, Damber JE, Borg A. BRCA2 mutation in a family with hereditary prostate cancer. Genes Chromosomes Cancer 2001;30:299\u2013301.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "2_CR59", "first-page": "4513", "volume": "60", "author": "S.A. Gayther", "year": "2000", "unstructured": "Gayther SA, de Foy KA, Harrington P, et al. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. Cancer Res 2000;60:4513\u20134518.", "journal-title": "Cancer Res"}, {"issue": "1", "key": "2_CR60", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1086/345310", "volume": "72", "author": "S.M. Edwards", "year": "2003", "unstructured": "Edwards SM, Kote-Jarai Z, Meitz J, et al. Cancer Research UK/British Prostate Group UK Familial Prostate Cancer Study Collaborators, British Association of Urological Surgeons Section of Oncology. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003;72(1):1\u201312.", "journal-title": "Am J Hum Genet"}, {"issue": "9", "key": "2_CR61", "doi-asserted-by": "crossref", "first-page": "2918", "DOI": "10.1158/1078-0432.CCR-03-0604", "volume": "10", "author": "T. Kirchhoff", "year": "2004", "unstructured": "Kirchhoff T, Kauff ND, Mitra N, et al. BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res 2004;10(9):2918\u20132921.", "journal-title": "Clin Cancer Res"}, {"issue": "10", "key": "2_CR62", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1136/jmg.40.10.787", "volume": "40", "author": "R.M. Giusti", "year": "2003", "unstructured": "Giusti RM, Rutter JL, Duray PH, et al. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet 2003;40(10):787\u2013792.", "journal-title": "J Med Genet"}, {"issue": "4", "key": "2_CR63", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1158/0008-5472.CAN-03-2502", "volume": "64", "author": "C. Cybulski", "year": "2004", "unstructured": "Cybulski C, Gorski B, Debniak T, et al. NBS1 is a prostate cancer susceptibility gene. Cancer Res 2004;64(4):1215\u20131219.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "2_CR64", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1086/346094", "volume": "72", "author": "X. Dong", "year": "2003", "unstructured": "Dong X, Wang L, Taniguchi K, et al. Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 2003;72(2):270\u2013280.", "journal-title": "Am J Hum Genet"}, {"issue": "6", "key": "2_CR65", "doi-asserted-by": "crossref", "first-page": "1416", "DOI": "10.1086/301879", "volume": "62", "author": "P. Berthon", "year": "1998", "unstructured": "Berthon P, Valerie A, Cohen-Akenine A, et al. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2\u201343. Am J Hum Genet 1998;62(6):1416\u20131424.", "journal-title": "Am J Hum Genet"}, {"key": "2_CR66", "unstructured": "Suarez BK, Lin J, Burmester JK, et al. A genome screen of multiplex sibships with prostate cancer. 66(3):933\u2013944.", "DOI": "10.1086/302818", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "2_CR67", "doi-asserted-by": "crossref", "first-page": "776", "DOI": "10.1086/302287", "volume": "64", "author": "M. Gibbs", "year": "1999", "unstructured": "Gibbs M, Stanford JL, McIndoe RA, et al. Evidence for a rare prostate cancer prostate cancer-susceptibility locus at chromosome 1p36. Hum Genet 1999;64(3):776\u2013787.", "journal-title": "Hum Genet"}, {"issue": "2", "key": "2_CR68", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1086/302771", "volume": "66", "author": "R. Berry", "year": "2000", "unstructured": "Berry R, Schaid DJ, Smith JR, et al. Linkage analyses at the chromosome 1 loci 1q24\u201325 (HPC1), 1q42.2\u201343 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer. Am J Hum Genet 2000;66(2):539\u2013546.", "journal-title": "Am J Hum Genet"}, {"issue": "2", "key": "2_CR69", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1038/84808", "volume": "27", "author": "S.V. Tavtigian", "year": "2001", "unstructured": "Tavtigian SV, Simrad J, Teng DH, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001;27(2):172\u2013180.", "journal-title": "Nat Genet"}, {"issue": "24", "key": "2_CR70", "doi-asserted-by": "crossref", "first-page": "1893", "DOI": "10.1093/jnci/89.24.1893", "volume": "89", "author": "C.L. Hsieh", "year": "1997", "unstructured": "Hsieh CL, Oakley-Girvan I, Gallagher RP, et al. Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 1997;89(24):1893\u20131894.", "journal-title": "J Natl Cancer Inst"}, {"issue": "1", "key": "2_CR71", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1086/302994", "volume": "67", "author": "R. Berry", "year": "2000", "unstructured": "Berry R, Schroeder JJ, French AJ, et al. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 2000;67(1):82\u201391.", "journal-title": "Am J Hum Genet"}, {"issue": "3", "key": "2_CR72", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1002/(SICI)1098-2272(200003)18:3<251::AID-GEPI5>3.0.CO;2-X", "volume": "18", "author": "E.L. Goode", "year": "2000", "unstructured": "Goode EL, Stanford JL, Chakrabarti L, et al. Linkage analysis of 150 high-risk prostate cancer families at 1q24\u201325. Genet Epidemiol 2000;18(3):251\u2013275.", "journal-title": "Genet Epidemiol"}, {"issue": "4", "key": "2_CR73", "doi-asserted-by": "crossref", "first-page": "326", "DOI": "10.1002/pros.10307", "volume": "57", "author": "E.M. Lange", "year": "2003", "unstructured": "Lange EM, Gillanders EM, Davis CC, et al. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 2003;57(4):326\u2013334.", "journal-title": "Prostate"}, {"issue": "4", "key": "2_CR74", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1002/pros.10302", "volume": "57", "author": "J. Schleutker", "year": "2003", "unstructured": "Schleutker J, Baffoe-Bonnie AB, et al. Genome-wide scan for linkage in Finnish Hereditary Prostate Cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25\u201326. Prostate 2003;57(4):280\u2013289.", "journal-title": "Prostate"}, {"issue": "4", "key": "2_CR75", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1002/pros.10308", "volume": "57", "author": "J.M. Cunningham", "year": "2003", "unstructured": "Cunningham JM, McDonnell SK, Marks A, et al. Mayo Clinic, Rochester, Minnesota. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study. Prostate 2003;57(4):335\u2013346.", "journal-title": "Prostate"}, {"issue": "4", "key": "2_CR76", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.1002/pros.10306", "volume": "57", "author": "J. Xu", "year": "2003", "unstructured": "Xu J, Gillanders EM, Isaacs SD, et al. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. Prostate 2003;57(4):320\u2013325.", "journal-title": "Prostate"}, {"issue": "4", "key": "2_CR77", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1002/pros.10303", "volume": "57", "author": "F. Wiklund", "year": "2003", "unstructured": "Wiklund F, Gillanders EM, Albertus JA, et al. Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate 2003;57(4):290\u2013297.", "journal-title": "Prostate"}, {"issue": "4", "key": "2_CR78", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1002/pros.10305", "volume": "57", "author": "M.F.D. Janer", "year": "2003", "unstructured": "Janer MFD, Stanford JL, Badzioch MD, et al. Genomic scan of 254 hereditary prostate cancer families. Prostate 2003;57(4):309\u2013319.", "journal-title": "Prostate"}, {"issue": "4", "key": "2_CR79", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1002/pros.10304", "volume": "57", "author": "J.S.S.B. Witte", "year": "2003", "unstructured": "Witte JSSB, Thiel B, Lin J, et al. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate 2003;57(4):298\u2013308.", "journal-title": "Prostate"}, {"issue": "4", "key": "2_CR80", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1002/pros.10301", "volume": "57", "author": "The International ACTANE Consortium", "year": "2003", "unstructured": "The International ACTANE Consortium. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium. Prostate 2003;57(4):270\u2013279.", "journal-title": "Prostate"}, {"issue": "1", "key": "2_CR81", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1086/302447", "volume": "65", "author": "H. Gronberg", "year": "1999", "unstructured": "Gronberg H, Smith J, Emanuelsson M, et al. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24\u201325 is restricted to families with early-onset prostate cancer. Am J Hum Genet 1999;65(1):134\u2013140.", "journal-title": "Am J Hum Genet"}, {"issue": "13", "key": "2_CR82", "doi-asserted-by": "crossref", "first-page": "955", "DOI": "10.1093/jnci/89.13.955", "volume": "89", "author": "K.A. Cooney", "year": "1997", "unstructured": "Cooney KA, McCarthy JD, Lange E, et al. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst 1997;89(13):955\u2013959.", "journal-title": "J Natl Cancer Inst"}, {"issue": "13", "key": "2_CR83", "doi-asserted-by": "crossref", "first-page": "2437", "DOI": "10.1093/hmg/8.13.2437", "volume": "8", "author": "S.L. Neuhausen", "year": "1999", "unstructured": "Neuhausen SL, Farnham JH, Kort E, Tavtigian SV, Skolnick MH, Cannon-Albright LA. Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees. Hum Mol Genet 1999;8(13):2437\u20132442.", "journal-title": "Hum Mol Genet"}, {"issue": "4", "key": "2_CR84", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1007/s004390100488", "volume": "108", "author": "J. Xu", "year": "2001", "unstructured": "Xu J, Zheng SL, Chang B, et al. Linkage of prostate cancer susceptibility loci to chromosome 1. Hum Genet 2001;108(4):335\u2013345.", "journal-title": "Hum Genet"}, {"issue": "2", "key": "2_CR85", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1086/514853", "volume": "61", "author": "R.A. McIndoe", "year": "1997", "unstructured": "McIndoe RA, Stanford JL, Gibbs M, et al. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24\u201325. Am J Hum Genet 1997;61(2):347\u2013353.", "journal-title": "Am J Hum Genet"}, {"issue": "3", "key": "2_CR86", "doi-asserted-by": "crossref", "first-page": "653", "DOI": "10.1086/301745", "volume": "62", "author": "R.A. Eeles", "year": "1998", "unstructured": "Eeles RA, Durocher F, Edwards S, et al. Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. Am J Hum Genet 1998;62(3):653\u2013658.", "journal-title": "Am J Hum Genet"}, {"issue": "5", "key": "2_CR87", "doi-asserted-by": "crossref", "first-page": "1197", "DOI": "10.1086/320103", "volume": "68", "author": "K.A. Goddard", "year": "2001", "unstructured": "Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001;68(5):1197\u20131206.", "journal-title": "Am J Hum Genet"}, {"issue": "3", "key": "2_CR88", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.1086/302807", "volume": "66", "author": "J. Xu", "year": "2000", "unstructured": "Xu J. Combined analysis of hereditary prostate cancer linkage to 1q24\u201325: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 2000;66(3):945\u2013957; erratum in Am J Hum Genet 2000;67(2):541\u2013542.", "journal-title": "Am J Hum Genet"}, {"issue": "2", "key": "2_CR89", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1038/ng823", "volume": "30", "author": "J. Carpten", "year": "2002", "unstructured": "Carpten J, Nupponen N, Isaacs S, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30(2):181\u2013184.", "journal-title": "Nat Genet"}, {"issue": "5", "key": "2_CR90", "doi-asserted-by": "crossref", "first-page": "1299", "DOI": "10.1086/340450", "volume": "70", "author": "A. Rokman", "year": "2002", "unstructured": "Rokman A, Ikonen T, Seppala EH, et al. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 2002;70(5):1299\u20131304; erratum in Am J Hum Genet 2002;71(1):215.", "journal-title": "Am J Hum Genet"}, {"issue": "4", "key": "2_CR91", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1038/ng1021", "volume": "32", "author": "G. Casey", "year": "2002", "unstructured": "Casey G, Neville PJ, Plummer SJ, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002;32(4):581\u2013583.", "journal-title": "Nat Genet"}, {"issue": "3", "key": "2_CR92", "doi-asserted-by": "crossref", "first-page": "e21", "DOI": "10.1136/jmg.40.3.e21", "volume": "40", "author": "H. Chen", "year": "2003", "unstructured": "Chen H, Griffen AR, Wu YQ, et al. RNASEL mutations in hereditary prostate cancer. J Med Genet 2003;40(3):e21.", "journal-title": "J Med Genet"}, {"issue": "2", "key": "2_CR93", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1038/ng1239", "volume": "35", "author": "L. Wang", "year": "2003", "unstructured": "Wang L, McDonnel SK, Cunningham JM, et al. No association of germline alteration of MSR1 with prostate cancer risk. Nat Genet 2003;35(2):128\u2013129.", "journal-title": "Nat Genet"}, {"issue": "8", "key": "2_CR94", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1038/sj.bjc.6600564", "volume": "87", "author": "J.C. Meitz", "year": "2002", "unstructured": "Meitz JC, Edwards SM, Easton DF, et al. Cancer Research UK/BPG UK Familial Prostate Cancer Study Collaborators. HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease. Br J Cancer 2002;87(8):905\u2013908.", "journal-title": "Br J Cancer"}, {"issue": "12", "key": "2_CR95", "doi-asserted-by": "crossref", "first-page": "947", "DOI": "10.1136/jmg.37.12.947", "volume": "37", "author": "M. Badzioch", "year": "2000", "unstructured": "Badzioch M, Eeles R, Leblanc G, et al. Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators. J Med Genet 2000;37(12):947\u2013949.", "journal-title": "J Med Genet"}, {"issue": "2", "key": "2_CR96", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1038/2477", "volume": "20", "author": "J. Xu", "year": "1998", "unstructured": "Xu J, Meyers D, Freije D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998;20(2):175\u2013179.", "journal-title": "Nat Genet"}, {"issue": "1", "key": "2_CR97", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1086/302960", "volume": "67", "author": "J.S. Witte", "year": "2000", "unstructured": "Witte JS, Goddard KA, Conti DV, et al. Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 2000;67(1):92\u201399.", "journal-title": "Am J Hum Genet"}, {"issue": "3", "key": "2_CR98", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1086/368230", "volume": "72", "author": "S.L. Slager", "year": "2003", "unstructured": "Slager SL, Schaid DJ, Cunningham JM, et al. Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet 2003;72(3):759\u2013762.", "journal-title": "Am J Hum Genet"}, {"issue": "4", "key": "2_CR99", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.1002/gcc.10165", "volume": "36", "author": "P.J. Neville", "year": "2003", "unstructured": "Neville PJ, Conti DV, Krumroy LM, et al. Prostate cancer aggressiveness locus on chromosome segment 19q12\u2013q13.1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer 2003;36(4):332\u2013339.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "2_CR100", "first-page": "1937", "volume": "55", "author": "R.A. Irvine", "year": "1995", "unstructured": "Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937\u20131940.", "journal-title": "Cancer Res"}, {"key": "2_CR101", "first-page": "4400", "volume": "81", "author": "D.O. Hardy", "year": "1996", "unstructured": "Hardy DO, Scher HI, Bogenreider T, et al. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400\u20134405.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "2_CR102", "doi-asserted-by": "crossref", "first-page": "166", "DOI": "10.1093/jnci/89.2.166", "volume": "89", "author": "S.A. Ingles", "year": "1997", "unstructured": "Ingles SA, Ross RK, Yu MC, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89:166\u2013170.", "journal-title": "J Natl Cancer Inst"}, {"key": "2_CR103", "first-page": "1194", "volume": "57", "author": "J.L. Stanford", "year": "1997", "unstructured": "Stanford JL, Just JJ, Gibbs M, et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997;57:1194\u20131198.", "journal-title": "Cancer Res"}, {"key": "2_CR104", "doi-asserted-by": "crossref", "first-page": "3320", "DOI": "10.1073/pnas.94.7.3320", "volume": "94", "author": "E. Giovannucci", "year": "1997", "unstructured": "Giovannucci E, Stampfer MJ, Krithivas K, et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997;94:3320\u20133323.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "2_CR105", "first-page": "1599", "volume": "3", "author": "J.M. Hakimi", "year": "1997", "unstructured": "Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 1997;3:1599\u20131608.", "journal-title": "Clin Cancer Res"}, {"key": "2_CR106", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1002/pros.1098", "volume": "48", "author": "E.A. Miller", "year": "2001", "unstructured": "Miller EA, Stanford JL, Hsu L, Noonan E, Ostrander EA. Polymorphic repeats in the androgen receptor gene in high-risk sibships. Prostate 2001;48:200\u2013205.", "journal-title": "Prostate"}, {"key": "2_CR107", "first-page": "5111", "volume": "60", "author": "A.W. Hsing", "year": "2000", "unstructured": "Hsing AW, Gao YT, Wu G, et al. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 2000;60:5111\u20135116.", "journal-title": "Cancer Res"}, {"key": "2_CR108", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y", "volume": "84", "author": "S.M. Edwards", "year": "1999", "unstructured": "Edwards SM, Badzioch MD, Minter R, et al. Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer 1999;84:458\u2013465.", "journal-title": "Int J Cancer"}, {"key": "2_CR109", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1016/S0140-6736(98)11282-5", "volume": "354", "author": "N.M. Makridakis", "year": "1999", "unstructured": "Makridakis NM, Ross RK, Pike MC, et al. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet 1999;354:975\u2013978.", "journal-title": "Lancet"}, {"key": "2_CR110", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1097/00008571-200106000-00007", "volume": "11", "author": "Z. Kote-Jarai", "year": "2001", "unstructured": "Kote-Jarai Z, Easton D, Edwards SM, et al. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 2001;11:325\u2013330.", "journal-title": "Pharmacogenetics"}, {"key": "2_CR111", "unstructured": "Walsh PC. Hereditary Prostate Cancer, podium talk at the annual meeting of the American Society of Clinical Oncology, 1996."}, {"issue": "4", "key": "2_CR112", "doi-asserted-by": "crossref", "first-page": "1478", "DOI": "10.1200/JCO.1997.15.4.1478", "volume": "15", "author": "P.A. Kupelian", "year": "1997", "unstructured": "Kupelian PA, Kupelian VA, Witte JS, Macklis R, Klein EA. Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. J Clin Oncol 1997;15(4):1478\u20131480.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "2_CR113", "doi-asserted-by": "crossref", "first-page": "66", "DOI": "10.1002/1097-0045(20000915)45:1<66::AID-PROS8>3.0.CO;2-W", "volume": "45", "author": "A. Valeri", "year": "2000", "unstructured": "Valeri A, Azzouzi R, Drelon E, et al. Early-onset hereditary prostate cancer is not associated with clinical and biological features. Prostate 2000;45(1):66\u201371.", "journal-title": "Prostate"}, {"issue": "6", "key": "2_CR114", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1038/sj.pcan.4500257", "volume": "1", "author": "E.A. Klein", "year": "1998", "unstructured": "Klein EA, Kupelian PA, Witte JS. Does a family history of prostate cancer result in more aggressive disease? Prostate Cancer Prostatic Dis 1998;1(6):297\u2013300.", "journal-title": "Prostate Cancer Prostatic Dis"}, {"issue": "3 pt 1", "key": "2_CR115", "first-page": "660", "volume": "160", "author": "G.S. Bova", "year": "1998", "unstructured": "Bova GS, Partin AW, Isaacs SD, et al. Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. 1998;160(3 pt 1):660\u2013663.", "journal-title": "Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy"}, {"issue": "35", "key": "2_CR116", "doi-asserted-by": "crossref", "first-page": "5871", "DOI": "10.1038/sj.onc.1207800", "volume": "23", "author": "C.S. Foster", "year": "2004", "unstructured": "Foster CS, Falconer A, Dodson AR, et al. Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 2004;23(35):5871\u20135879.", "journal-title": "Oncogene"}, {"issue": "4", "key": "2_CR117", "doi-asserted-by": "crossref", "first-page": "1478", "DOI": "10.1200/JCO.1997.15.4.1478", "volume": "15", "author": "P.A. Kupelian", "year": "1997", "unstructured": "Kupelian PA, Kupelian VA, Witte JS, Macklis R, Klein EA. Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. J Clin Oncol 1997;15(4):1478\u20131480.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "2_CR118", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/j.radonc.2003.12.011", "volume": "71", "author": "L. Potters", "year": "2004", "unstructured": "Potters L, Klein EA, Kattan MW, et al. Monotherapy for stage T1\u2013T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004;71(1):29\u201333.", "journal-title": "Radiother Oncol"}, {"issue": "16", "key": "2_CR119", "doi-asserted-by": "crossref", "first-page": "3376", "DOI": "10.1200/JCO.2002.01.150", "volume": "20", "author": "P.A. Kupelian", "year": "2002", "unstructured": "Kupelian PA, Elshaikh M, Reddy CA, Zippe C, Klein EA. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol 2002;20(16):3376\u20133385.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "2_CR120", "doi-asserted-by": "crossref", "first-page": "735", "DOI": "10.1016/S0090-4295(98)00398-7", "volume": "52", "author": "A.L. Hanlon", "year": "1998", "unstructured": "Hanlon AL, Hanks GE. Patterns of inheritance and outcome in patients treated with external beam radiation for prostate cancer. Urology 1998;52(5):735\u2013738.", "journal-title": "Urology"}, {"issue": "6", "key": "2_CR121", "doi-asserted-by": "crossref", "first-page": "1193", "DOI": "10.1016/S0090-4295(03)00033-5", "volume": "61", "author": "A.R. Azzouzi", "year": "2003", "unstructured": "Azzouzi AR, Valeri A, Cormier L, Fournier G, Mangin P, Cussenot O. Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases. Urology 2003;61(6):1193\u20131197.", "journal-title": "Urology"}, {"issue": "1", "key": "2_CR122", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5", "volume": "77", "author": "H. Gronberg", "year": "1996", "unstructured": "Gronberg H, Damber L, Damber JE. Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 1996;77(1):138\u2013143.", "journal-title": "Cancer"}, {"issue": "6", "key": "2_CR123", "doi-asserted-by": "crossref", "first-page": "2197", "DOI": "10.1016/S0022-5347(01)68194-1", "volume": "158", "author": "P.A. Kupelian", "year": "1997", "unstructured": "Kupelian PA, Klein EA, Witte JS, Kupelian VA, Suh JH. Familial prostate cancer: a different disease? J Urol 1997;158(6):2197\u20132201.", "journal-title": "J Urol"}, {"key": "2_CR124", "unstructured": "American Urological Association. Prostate Cancer Awareness For Men: A Doctor\u2019s Guide for Patients. AUA, 2001:4\u20135."}, {"key": "2_CR125", "unstructured": "Cancer Reference Information: Can Prostate Cancer Be Found Early? American Cancer Society. October 3, 2001."}, {"issue": "3", "key": "2_CR126", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1056/NEJMoa030660", "volume": "349", "author": "I.M. Thompson", "year": "2003", "unstructured": "Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349(3):215\u2013224.", "journal-title": "N Engl J Med"}, {"issue": "3\u20134", "key": "2_CR127", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1023/A:1021267128567", "volume": "21", "author": "R. Lieberman", "year": "2002", "unstructured": "Lieberman R. Chemoprevention of prostate cancer: current status and future directions. Cancer Metastasis Rev 2002;21(3\u20134):297\u2013309.", "journal-title": "Cancer Metastasis Rev"}, {"issue": "5", "key": "2_CR128", "doi-asserted-by": "crossref", "first-page": "730", "DOI": "10.1046/j.1464-410x.1998.00630.x", "volume": "81", "author": "L.C. Clark", "year": "1998", "unstructured": "Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998;81(5):730\u2013734.", "journal-title": "Br J Urol"}, {"issue": "3", "key": "2_CR129", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1097/00042307-200405000-00002", "volume": "14", "author": "E.A. Klein", "year": "2004", "unstructured": "Klein EA, Thompson IM. Update on chemoprevention of prostate cancer. Curr Opin Urol 2004;14(3):143\u2013149.", "journal-title": "Curr Opin Urol"}, {"key": "2_CR130", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1007/978-3-642-55647-0_19", "volume": "163", "author": "E.A. Klein", "year": "2003", "unstructured": "Klein EA. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial. Recent Results Cancer Res 2003;163:212\u2013225; discussion 264\u2013266.", "journal-title": "Recent Results Cancer Res"}, {"issue": "9", "key": "2_CR131", "doi-asserted-by": "crossref", "first-page": "1172", "DOI": "10.1111/j.1464-410X.2004.04889.x", "volume": "93", "author": "S. Kommu", "year": "2004", "unstructured": "Kommu S, Sharifi R, Edwards S, Eeles R. Proteomics and urine analysis-a potential promising new tool in urology. BJU Int 2004;93(9):1172\u20131173.", "journal-title": "BJU Int"}, {"issue": "3", "key": "2_CR132", "doi-asserted-by": "crossref", "first-page": "826", "DOI": "10.1016/S0022-5347(17)36733-2", "volume": "148", "author": "W.P. McWhorter", "year": "1992", "unstructured": "McWhorter WP, Hernandez AD, Meikle AW, et al. A screening study of prostate cancer in high risk families. J Urol 1992;148(3):826\u2013828.", "journal-title": "J Urol"}, {"issue": "9377", "key": "2_CR133", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1016/S0140-6736(03)13823-8", "volume": "362", "author": "M. Tischkowitz", "year": "2003", "unstructured": "Tischkowitz M, Eeles R, IMPACT study: Identification of Men with genetic predisposition to Prostate Cancer and its Clinical Treatment collaborators. Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer. Lancet 2003;362(9377):80; author reply 80.", "journal-title": "Lancet"}], "container-title": ["Urological Cancers"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/1-84628-015-X_2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T15:35:53Z", "timestamp": 1555688153000}, "score": 25.511177, "issued": {"date-parts": [[null]]}, "ISBN": ["185233911X"], "references-count": 133, "URL": "http://dx.doi.org/10.1007/1-84628-015-x_2", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:48Z", "timestamp": 1574489028242}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1997, 10, 1]], "date-time": "1997-10-01T00:00:00Z", "timestamp": 875664000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1997, 10]]}, "DOI": "10.1038/bjc.1997.498", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:50:19Z", "timestamp": 1295005819000}, "page": "992-1000", "source": "Crossref", "is-referenced-by-count": 16, "title": ["No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters"], "prefix": "10.1038", "volume": "76", "author": [{"given": "SM", "family": "Edwards", "sequence": "first", "affiliation": []}, {"name": "The CRC/BPG UK Familial Prostate Cancer Study Collaborators", "sequence": "first", "affiliation": []}, {"given": "DP", "family": "Dearnaley", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Ardern-Jones", "sequence": "additional", "affiliation": []}, {"given": "RA", "family": "Hamoudi", "sequence": "additional", "affiliation": []}, {"given": "DF", "family": "Easton", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Ford", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Shearer", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Dowe", "sequence": "additional", "affiliation": []}, {"given": "RA", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1997498.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1997498", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1997498.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T09:10:14Z", "timestamp": 1552900214000}, "score": 25.270184, "issued": {"date-parts": [[1997, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 10]]}, "issue": "8"}, "alternative-id": ["BFbjc1997498"], "URL": "http://dx.doi.org/10.1038/bjc.1997.498", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:53Z", "timestamp": 1574489033589}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "11", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1998, 12, 1]], "date-time": "1998-12-01T00:00:00Z", "timestamp": 912470400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1998, 12]]}, "DOI": "10.1038/bjc.1998.703", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:57:16Z", "timestamp": 1295006236000}, "page": "1430-1433", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1"], "prefix": "10.1038", "volume": "78", "author": [{"given": "WD", "family": "Dunsmuir", "sequence": "first", "affiliation": []}, {"name": "The CRC/BPG UK Familial Prostate Cancer Study Collaborators", "sequence": "first", "affiliation": []}, {"given": "SM", "family": "Edwards", "sequence": "additional", "affiliation": []}, {"given": "SR", "family": "Lakhani", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Young", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Corbishley", "sequence": "additional", "affiliation": []}, {"given": "RS", "family": "Kirby", "sequence": "additional", "affiliation": []}, {"given": "DP", "family": "Dearnaley", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Dowe", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Ardern-Jones", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Kelly", "sequence": "additional", "affiliation": []}, {"given": "RA", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1998703.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1998703", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1998703.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T09:13:15Z", "timestamp": 1552900395000}, "score": 25.086817, "issued": {"date-parts": [[1998, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 12]]}, "issue": "11"}, "alternative-id": ["BFbjc1998703"], "URL": "http://dx.doi.org/10.1038/bjc.1998.703", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T01:01:55Z", "timestamp": 1574557315449}, "reference-count": 0, "publisher": "Oxford University Press", "isbn-type": [{"value": "9780199672844", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2014, 8]]}, "DOI": "10.1093/med/9780199672844.003.0010", "type": "book-chapter", "created": {"date-parts": [[2014, 10, 31]], "date-time": "2014-10-31T09:36:36Z", "timestamp": 1414748196000}, "page": "84-92", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Genetics of prostate cancer"], "prefix": "10.1093", "author": [{"given": "Audrey", "family": "Ardern-Jones", "sequence": "first", "affiliation": []}, {"given": "Elizabeth", "family": "Bancroft", "sequence": "additional", "affiliation": []}, {"given": "Rosalind", "family": "Eeles", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["Genetics for Health Professionals in Cancer Care"], "deposited": {"date-parts": [[2017, 11, 7]], "date-time": "2017-11-07T15:31:29Z", "timestamp": 1510068689000}, "score": 24.830029, "issued": {"date-parts": [[2014, 8]]}, "ISBN": ["9780199672844"], "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780199672844.003.0010"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}